<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/388447</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;388447</article-id><article-id pub-id-type="other" hwp:sub-type="slug">388447</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">388447</article-id><article-id pub-id-type="other" hwp:sub-type="tag">388447</article-id><article-version>1.3</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Evolutionary Biology" hwp:journal="biorxiv"><subject>Evolutionary Biology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">The loops of the N-SH2 binding cleft do not serve as allosteric switch in SHP2 activation</article-title></title-group><author-notes hwp:id="author-notes-1"><fn id="n1" fn-type="others" hwp:id="fn-1"><p hwp:id="p-1">All authors contributed to the final manuscript.</p></fn><fn id="n2" fn-type="others" hwp:id="fn-2"><p hwp:id="p-2">The authors declare no competing interests.</p></fn><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>1</label>To whom correspondence should be addressed. E-mail: <email hwp:id="email-1">manselm@gwdg.de</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" corresp="yes" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Anselmi Massimiliano"><surname>Anselmi</surname><given-names>Massimiliano</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">a</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">b</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Hub Jochen S."><surname>Hub</surname><given-names>Jochen S.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">a</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2"><label>a</label><institution hwp:id="institution-1">Theoretical Physics and Center for Biophysics, Saarland University</institution>, 66123 Saarbrücken, <country>Germany</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1"><label>b</label><institution hwp:id="institution-2">Institute for Microbiology and Genetics, Georg-August-Universität Göttingen</institution>, 37077 Göttingen, <country>Germany</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2018-08-10T07:39:23-07:00">
    <day>10</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-01-08T23:06:18-08:00">
    <day>8</day><month>1</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2018-08-10T07:45:54-07:00">
    <day>10</day><month>8</month><year>2018</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-01-08T23:09:23-08:00">
    <day>8</day><month>1</month><year>2021</year>
  </pub-date><elocation-id>388447</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2018-08-10"><day>10</day><month>8</month><year>2018</year></date>
<date date-type="rev-recd" hwp:start="2021-01-08"><day>08</day><month>1</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-01-08"><day>08</day><month>1</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-3">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="388447.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/external-links" xlink:role="external-links" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/388447v3.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="388447.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/388447v3/388447v3.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/388447v3/388447v3.htslp"/><abstract hwp:id="abstract-1"><p hwp:id="p-4">The Src homology-2 domain containing phosphatase SHP2 is a critical regulator of signal transduction, being implicated in cell growth and differentiation. Activating mutations cause developmental disorders and act as oncogenic drivers in hematologic cancers. SHP2 is activated by phosphopeptide binding to the N-SH2 domain, triggering the release of N-SH2 from the catalytic PTP domain. Based on early crystallographic data, it has been widely accepted that opening of the binding cleft of N-SH2 serves as the key “allosteric switch” driving SHP2 activation. To test the putative coupling between binding cleft opening and SHP2 activation as assumed by the “allosteric switch” model, we critically reviewed structural data of SHP2 and we used extensive molecular dynamics (MD) simulation and free energy calculations of isolated N-SH2 in solution, SHP2 in solution, and SHP2 in a crystal environment. Our results demonstrate that the binding cleft in N-SH2 is constitutively flexible and open in solution, and that a closed cleft found in certain structures is a consequence of crystal contacts. The degree of opening of the binding cleft has only a negligible effect on the free energy of SHP2 activation. Instead, SHP2 activation is greatly favored by the opening of the central <italic toggle="yes">β</italic>- sheet of N-SH2. We conclude that opening of the N-SH2 binding cleft is not the key allosteric switch triggering SHP2 activation.</p><sec hwp:id="sec-1"><title hwp:id="title-1">Significance Statement</title><p hwp:id="p-5">SHP2 is a multi-domain protein, playing an important role in up-regulating cellular processes such as cell survival, proliferation, and programmed cell death. SHP2 mutations cause developmental disorders and were found in many cancer types, including neuroblastoma, breast cancer, and leukemia. In healthy cells, SHP2 mainly takes an autoinhibited, inactive form, and SHP2 is activated upon binding of phosphopeptides to the N-SH2 domain. For the past two decades, the widening of the binding cleft upon peptide binding has been considered as the key event driving SHP2 activation. Here, by analyzing crystallographic data and molecular simulations, we demonstrate that the binding cleft in N-SH2 is, instead, already open and accessible in solution, and its degree of opening does not influence SHP2 activation.</p></sec></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><kwd hwp:id="kwd-1">Molecular dynamics simulations</kwd><kwd hwp:id="kwd-2">Phosphatases</kwd><kwd hwp:id="kwd-3">Allosteric regulation</kwd></kwd-group><counts><page-count count="10"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-2">Competing Interest Statement</title><p hwp:id="p-6">The authors have declared no competing interest.</p></notes><fn-group content-type="external-links" hwp:id="fn-group-1"><fn fn-type="dataset" hwp:id="fn-3"><p hwp:id="p-7">
<ext-link l:rel="related" l:ref-type="uri" l:ref="https://github.com/garniergere/Reference.Db.SNPs.Quercus" ext-link-type="uri" xlink:href="https://github.com/garniergere/Reference.Db.SNPs.Quercus" hwp:id="ext-link-2">https://github.com/garniergere/Reference.Db.SNPs.Quercus</ext-link>
</p></fn></fn-group></notes></front><body><p hwp:id="p-8"><bold>S</bold>rc-homology-2-containing protein tyrosine phosphatase 2 (SHP2), encoded by the <italic toggle="yes">PTPN11</italic> gene, is a classical non-receptor protein tyrosine phosphatase (PTP). It has emerged as a key downstream regulator of several receptor tyrosine kinases (RTKs) and cytokine receptors, functioning as positive or negative modulator in multiple signaling pathways (<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>–<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>). Germline mutations in the human <italic toggle="yes">PTPN11</italic> gene have been associated with Noonan syndrome and with Noonan syndrome with multiple lentigines (formerly known as LEOPARD syndrome), two multisystem developmental diseases (<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>–<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>). Somatic <italic toggle="yes">PTPN11</italic> mutations were also linked with several types of human malignancies (<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>–<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>), such as myeloid leukemia (<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>, <xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>–<xref ref-type="bibr" rid="c30" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>).</p><p hwp:id="p-9">The structure of SHP2 includes two tandemly-arranged Src homology 2 domains (SH2), called N-SH2 and C-SH2, followed by the catalytic protein tyrosine phosphatase (PTP) domain, and a C-terminal tail with a poorly characterized function (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig. 1</xref>) (<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>). The SH2 domains are structurally conserved recognition elements (<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>) that allow SHP2 to bind signaling peptides containing a phosphorylated tyrosine (pY) (<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>). The N-SH2 domain consists of a central antiparallel <italic toggle="yes">β</italic>-sheet, composed of three <italic toggle="yes">β</italic>-strands, denoted <italic toggle="yes">β</italic>B, <italic toggle="yes">β</italic>C and <italic toggle="yes">β</italic>D, flanked by two <italic toggle="yes">α</italic>-helices, denoted <italic toggle="yes">α</italic>A and <italic toggle="yes">α</italic>B (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig. 1A</xref>). The peptide binds in an extended conformation to the cleft that is perpendicular to the plane of the <italic toggle="yes">β</italic>-sheet (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref>). N-SH2 contains a conserved affinity pocket covered by the BC loop (also called phosphate-binding loop or pY loop), whose interaction with pY increases the binding of the peptide by 1000-fold relative to unphosphorylated counterparts (<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>). Residues downstream to the pY bind to a more variable, less conserved site, which confers binding specificity and which is flanked by the EF and BG loops (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>).</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2 xref-fig-1-3 xref-fig-1-4 xref-fig-1-5"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig. 1.</label><caption hwp:id="caption-1"><p hwp:id="p-10">(A) Cartoon representation of the N-SH2 domain in complex with the IRS-1 pY895 peptide (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-2" hwp:rel-id="ref-34">34</xref>). The peptide, shown in cyan, comprises the phosphotyrosine and residues from position +1 to +5 relative to the phosphotyrosine (see labels). Functionally important loops are highlighted in color: BC “pY” loop (green), DE “blocking loop” (light blue), EF loop (magenta), BG loop (deep pink). The phosphotyrosine binds the site delimited by the pY loop and the central <italic toggle="yes">β</italic>-sheet (<italic toggle="yes">β</italic>B, <italic toggle="yes">β</italic>C, <italic toggle="yes">β</italic>D strands). EF and BG loops delimit the binding cleft (+5 site), where the peptide residue in position +5 is settled. (B) Crystal structure of autoinhibited SHP2 (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>): the N-SH2 domain (cyan cartoon) blocks the catalytic site (red) of the PTP domain (pink) with the blocking loop (blue). The N-SH2 domain is connected to PTP in tandem with the homologous C-SH2 domain (orange). Closure of the N-SH2 binding cleft (green region), delimited by the EF and BG loops (magenta and deep pink), precludes high-affinity phosphopeptide binding. According the “allosteric switch” model, the change in shape of the N-SH2 domain, which accompanies binding of phosphopeptide (yellow), perturbs surface complementarity for the PTP active site, thus promoting N-SH2 dissociation from the PTP domain. (C) Crystal structure of SHP2<sup>E76K</sup> (<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>): the open conformation reveals a 120°rotation of the C-SH2 domain, relocation of the N-SH2 domain to a PTP surface opposite the active site, and a solvent-exposed catalytic pocket.</p></caption><graphic xlink:href="388447v3_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><p hwp:id="p-11">In 1998, the first crystallographic structure of SHP2 at 2 Å resolution (pdbID 2SHP) revealed that the N-SH2 domain tightly interacts with the PTP domain (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-3" hwp:rel-id="F1">Fig. 1B</xref>), so that the DE loop of N-SH2, thereafter indicated as “blocking loop”, occludes the active site of PTP, forcing SHP2 into an autoinhibited “closed” state (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-2" hwp:rel-id="ref-37">37</xref>). SHP2 structures of the active “open” state, obtained for the basally active, leukemia-associated E76K mutant, showed an alternative relative arrangement of N-SH2 and PTP, that exposed the active site of the PTP domain to the solvent (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-4" hwp:rel-id="F1">Fig. 1C</xref>) (<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-2" hwp:rel-id="ref-38">38</xref>). Unexpectedly, in both the autoinhibited and the active state of SHP2, the N-SH2 ligand binding site is exposed to solvent and does not directly interact with PTP or other domains (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-3" hwp:rel-id="ref-37">37</xref>–<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref>). Hence, the need for an allosteric mechanism was proposed, according to which the binding of a phosphopeptide triggers a series of structural rearrangements in the N-SH2 domain to drive its release from PTP and the consequent activation of SHP2 (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-4" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-2" hwp:rel-id="ref-39">39</xref>).</p><p hwp:id="p-12">The comparison of the autoinhibited structure of SHP2 (pdbID 2SHP) (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-5" hwp:rel-id="ref-37">37</xref>) with the existing structures of the isolated N-SH2 domain, either in the absence of (pdbID 1AYD) (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-3" hwp:rel-id="ref-34">34</xref>) or in complex with a phosphopeptide (pdbID 1AYA, 1AYB, 4QSY) (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-4" hwp:rel-id="ref-34">34</xref>), showed that the EF and BG loops of the N-SH2 domain may undergo large conformational changes (<xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-5" hwp:rel-id="F1">Fig. 1B</xref>). In the autoinhibited structure of SHP2, the N-SH2 domain shares surface complementarity with the PTP catalytic site, but, as a result of the displacement of the EF loop towards the BG loop, it also contains a closed binding cleft that renders the N-SH2 domain unable to accommodate the C-terminal part of the phosphopeptide, in contrast to the isolated N-SH2 domain that exhibits an open binding cleft. Therefore, peptide binding seems only compatible with the conformation of isolated N-SH2, but not with the conformation of N-SH2 in autoinhibited SHP2 (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-6" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-3" hwp:rel-id="ref-39">39</xref>).</p><p hwp:id="p-13">Because (i) the closure of the binding cleft in N-SH2 has been ascribed to its interaction with PTP, and (ii) the conformation adopted by the EF loop correlates with the activation of SHP2 in available structural data, the EF loop has been suggested as the key “allosteric switch” that drives the release of N-SH2 from PTP (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-7" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-4" hwp:rel-id="ref-39">39</xref>). In light of that, conformation selection (<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>, <xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>, <xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>) and induced fit (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref>) models were put forward for the molecular events leading to functional activation of SHP2; however, both models consider the conformational change involving the EF loop as the key mechanism that drives SHP2 opening (<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-2" hwp:rel-id="ref-9">9</xref>, <xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-2" hwp:rel-id="ref-21">21</xref>, <xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-2" hwp:rel-id="ref-40">40</xref>, <xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-2" hwp:rel-id="ref-41">41</xref>). In conclusion, it has been widely accepted that the N-SH2 binding cleft, delimited by the EF and the BG loop, plays the role of an allosteric switch for the activation of SHP2 (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-5" hwp:rel-id="ref-39">39</xref>, <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref>). Accordingly, the binding of a ligand at the binding cleft of the N-SH2 domain would induce a transmitted conformational change that prevents PTP domain binding on the other side of N-SH2, and <italic toggle="yes">vice versa</italic> (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-8" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-6" hwp:rel-id="ref-39">39</xref>).</p><p hwp:id="p-14">However, the “allosteric switch” model does not explain how the signal, coming from the displacement of the EF loop, is propagated to the rest of the protein (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-7" hwp:rel-id="ref-39">39</xref>). In addition, considering that the EF loop might be flexible, the comparison of crystallographic structures does not provide the energetic penalties involved in the motion of the EF loop and, consequently, the degree of destabilization of the N-SH2/PTP complex upon the binding cleft opening (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-8" hwp:rel-id="ref-39">39</xref>). Hence, the role of the EF loop as the key allosteric switch has not been rationalized in energetic terms.</p><p hwp:id="p-15">Recently, an allosteric interaction in N-SH2 has been proposed as an alternative mechanism of SHP2 activation (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>). Molecular dynamics (MD) simulations have shown that the N-SH2 domain may adopt two distinct conformations, denoted as <italic toggle="yes">α</italic>- and <italic toggle="yes">β</italic>-state, which differ primarily in the conformation of the central <italic toggle="yes">β</italic>-sheet. In the <italic toggle="yes">α</italic>-state, the central <italic toggle="yes">β</italic>-sheet is open, adopting a Y-shaped structure; in the <italic toggle="yes">β</italic>-state, the central <italic toggle="yes">β</italic>-sheet is closed, adopting a parallel structure. The MD simulations suggested that the <italic toggle="yes">β</italic>-state of N-SH2 stabilizes the N-SH2/PTP contacts and, hence, the autoinhibited SHP2 conformation. In contrast, the <italic toggle="yes">α</italic>-state drives the N-SH2 dissociation and SHP2 activation. Notably, the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model of activation rationalized modified basal activity and responsiveness to ligand stimulation of certain mutations at codon 42 (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">15</xref>). However, the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model seems to contrast the previously suggested “allosteric switch” model.</p><p hwp:id="p-16">To resolve this discrepancy, we revisited the “allosteric switch” model. We critically reviewed available crystallographic data of SHP2 in the autoinhibited state. In addition, we used MD simulations, free energy calculations, and enhanced sampling techniques to reveal the conformational dynamics of the binding cleft delimited by the BG and the EF loop in the isolated N-SH2 domain in water, in SHP2 in water, and in SHP2 in a crystal environment. Our results suggest that the binding cleft of N-SH2 is constitutively flexible and the effect of its degree of opening on the activation of SHP2 is negligible. In addition, free energy calculations revealed that, in the crystal environment, the closure of the binding cleft is not due to the allosteric interaction with the PTP domain, but instead a result of the crystal contacts affecting the binding cleft conformation.</p><sec id="s1" hwp:id="sec-2"><label>1.</label><title hwp:id="title-3">Results</title><sec id="s1a" hwp:id="sec-3"><label>A.</label><title hwp:id="title-4">N-SH2 domain loops are characterized by structural disorder</title><p hwp:id="p-17">In crystal structures, the EF and the BG loop have been generally modeled such that the binding cleft of the N-SH2 domain is inaccessible to the ligand (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-2" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-9" hwp:rel-id="ref-37">37</xref>). To test whether the closed binding cleft is supported by available data, we first evaluated Ramachandran outliers, electron densities, residue-wise crystallographic R-factors (Z-scores), as well as crystal contacts in the loop regions. The evaluation of the first resolved crystallographic structure of autoinhibited SHP2 (2SHP) (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-10" hwp:rel-id="ref-37">37</xref>), performed by MolProbity (<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref>), revealed that the BG loop (residues 84–98) adopts a configuration compatible with a closed binding cleft only at the cost of significant energetic penalties. In particular, the Ramachandran angles of the residues Asn<sup>92</sup> (<italic toggle="yes">ϕ</italic> = 58.4°; <italic toggle="yes">ψ</italic> = 118.9°) and Asp<sup>94</sup> (<italic toggle="yes">ϕ</italic> = −42.0°; <italic toggle="yes">ψ</italic> = 95.5°) represent outliers, being represented in less than 0.01% of the samples in protein databank; in case of His<sup>84</sup> (<italic toggle="yes">ϕ</italic> = −145.7°; <italic toggle="yes">ψ</italic> = 64.1°), Glu<sup>90</sup> (<italic toggle="yes">ϕ</italic> = −87.7°; <italic toggle="yes">ψ</italic> = −109.2°), and Gly<sup>93</sup> (<italic toggle="yes">ϕ</italic> = 73.9°; <italic toggle="yes">ψ</italic> = −46.0°), the conformations are allowed yet disfavored, being represented in only 1.24 %, 0.07 % and 1.4 % of the samples, respectively. In the light of the “allosteric switch” model, these unfavorable conformations may be justified considering that the N-SH2 domain structure is forced by PTP in a tensed conformation, which may be turned into a relaxed conformation only upon ligand binding or upon the release from PTP (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-11" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-9" hwp:rel-id="ref-39">39</xref>–<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-3" hwp:rel-id="ref-41">41</xref>). However, inspection of the electron density map showed that the electron densities at BG loop, EF loop and pY loop were much lower compared to the density of the nearby <italic toggle="yes">β</italic>-strands (<italic toggle="yes">SI Appendix</italic>, Fig. S1), indicating increased disorder, and therefore a reduced structural definition of these loops.</p><p hwp:id="p-18">The 2SHP model was refined to a crystallographic R-factor of 0.2 with a R<sub>free</sub> of 0.27 (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-12" hwp:rel-id="ref-37">37</xref>), characterizing a structure with overall acceptable quality (<xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref>). However, the R-factor is a global measure of the model accuracy. In proteins, some regions and strands may be intrinsically disordered such that they cannot be resolved by x-ray diffraction irrespective of the resolution and the overall quality of the experimental data. For this reason, the Z-score has been used as a measure of local model accuracy (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref>, <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref>). The Z-score is given by <italic toggle="yes">Z</italic> = (<italic toggle="yes">R</italic> − ⟨<italic toggle="yes">R</italic>⟩<sub>res</sub>)<italic toggle="yes">/σ</italic><sub>res</sub> (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-2" hwp:rel-id="ref-46">46</xref>–<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">48</xref>), where ⟨<italic toggle="yes">R</italic>⟩<sub>res</sub> and <italic toggle="yes">σ</italic><sub>res</sub> are respectively the expected R-factor and the standard deviation of the R-factor values, calculated with the same amino acid in structures within the same resolution range. For instance, for the case of 2SHP with a resolution of 1.95 Å, the R-factor of each residue is compared with the expected R-factor and standard deviation detected from the same kind of residue in all structures of the database with resolution between 1.8 and 2.0 Å (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-2" hwp:rel-id="ref-48">48</xref>). A large, positive spike in a Z-score plot implies that a residue has an R-factor value that is considerably worse than that of the average residue of the same type in structures determined at similar resolution (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-3" hwp:rel-id="ref-48">48</xref>). Z-scores are considered as outliers if greater than 2 (<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-3" hwp:rel-id="ref-46">46</xref>, <xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-4" hwp:rel-id="ref-48">48</xref>).</p><p hwp:id="p-19">The structures of the N-SH2 domain belonging to the two SHP2 chains, A and B, in the 2SHP asymmetric unit are depicted in <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig. 2A</xref> (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-13" hwp:rel-id="ref-37">37</xref>). The backbone is colored according to the Z-score values reported in <xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Fig. 2B</xref>. Evidently, the regions colored in red corresponding to the BG and to the pY loop are poorly resolved, with Z-score values far above the threshold. Similarly, for the EF loop the Z-scores are barely fair in case of chain B, whereas in chain A the corresponding Z-scores are good.</p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig. 2.</label><caption hwp:id="caption-2"><p hwp:id="p-20">(A) Structures of the N-SH2 domain belonging respectively to the chain A and B of the asymmetric unit reported in the crystal structure of autoinhibited SHP2 (pdbID 2SHP (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-14" hwp:rel-id="ref-37">37</xref>)). The backbone is colored on the base of the R-factor Z-scores reported in (B). The outlier threshold of 2 is indicated by dashed lines.</p></caption><graphic xlink:href="388447v3_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-21">The “allosteric switch” model formulation was based on the conformation adopted by the BG and the EF loop in the 2SHP crystal structure (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-15" hwp:rel-id="ref-37">37</xref>), thus the validation of the model would require that those loops be univocally defined. However, the analysis of the electron density map, and the Z-scores reveal that the loops are poorly resolved compared to the rest of the protein. Instead, the loops have been modeled without adequate electron density, and forced into a geometry with significant structural outliers.</p></sec><sec id="s1b" hwp:id="sec-4"><label>B.</label><title hwp:id="title-5">The BG loop is generally poorly resolved in crystal structures of autoinhibited SHP2</title><p hwp:id="p-22">Together with the 2SHP structure (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-16" hwp:rel-id="ref-37">37</xref>), we computed Z-scores for other, more recent crystal structures of autoinhibited SHP2, comprising either wild type or functional mutants (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-3" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref>, <xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">50</xref>). <xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref> lists the crystal structures considered in this study, spanning resolutions from 1.87 to 2.7 Å. <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Fig. 3</xref> presents the Z-scores in color scale, for functionally important loop regions, corresponding to the pY loop (Ser<sup>34</sup>–Asp<sup>40</sup>, dark green), the EF loop (Tyr<sup>66</sup>–Glu<sup>69</sup>, purple) and the BG loop (Gly<sup>86</sup>–Glu<sup>97</sup>, pink). In most of the structures, the residues of the BG loop are either missing (blank spaces) or modeled without adequate electron density (yellow-red squares), confirming that BG loop is often disordered and therefore poorly resolved by x-ray diffraction. Likewise, the pY loop is sometimes missing or poorly resolved, although it is less affected by structural disorder than BG loop. In contrast, the short EF loop is marginally affected by structural disorder, being resolved in nearly all crystal structures, although Z-scores for residue Tyr<sup>66</sup> are often poor. Taken together, the Z-scores detected in many crystal structures confirm that loops represent flexible regions of the N-SH2 domain, in particular the BG loop. Notable exceptions are a number of high-quality crystal structures (4DGP, 4OHH, 5I6V) (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-4" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-2" hwp:rel-id="ref-49">49</xref>, <xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-2" hwp:rel-id="ref-50">50</xref>), in which the loops have been clearly resolved. These structures with well-resolved loops enabled us to further analyze a putative effect of crystal packing on loop conformations.</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-3"><p hwp:id="p-23">Experimental data of autoinibited SHP2 crystal structures</p></caption><graphic xlink:href="388447v3_tbl1" position="float" orientation="portrait" hwp:id="graphic-3"/></table-wrap><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3" hwp:rev-id="xref-fig-3-1 xref-fig-3-2 xref-fig-3-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Fig. 3.</label><caption hwp:id="caption-4"><p hwp:id="p-24">Tile plot of the R-factor Z-scores, calculated for crystal structures of autoinhibited SHP2. Z-scores are reported in color scale for each residue (blank spaces indicate missing residues), belonging to functionally important loop regions, corresponding to the pY loop (Ser<sup>34</sup>–Asp<sup>40</sup>, dark green), the EF loop (Tyr<sup>66</sup>–Glu<sup>69</sup>, purple) and the BG loop (Gly<sup>86</sup>–Glu<sup>97</sup>, pink).</p></caption><graphic xlink:href="388447v3_fig3" position="float" orientation="portrait" hwp:id="graphic-4"/></fig></sec><sec id="s1c" hwp:id="sec-5"><label>C.</label><title hwp:id="title-6">N-SH2 interacts with other copies of SHP2 in crystal structures</title><p hwp:id="p-25">In the crystal environment, proteins do not adopt the same biological assembly according their physiological conditions, but instead every protein is surrounded by other copies of the same protein, establishing close and rather extensive interactions that stabilize the crystal in a particular space group symmetry. If functionally relevant or even flexible regions are involved in such crystal contacts, the conformations of those regions must be interpreted with care.</p><p hwp:id="p-26"><xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig. 4A</xref> shows the surrounding of the N-SH2 domain for the structure 4DGP, which produced good Z-scores even for the BG, EF, and pY loops (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-5" hwp:rel-id="ref-16">16</xref>). Evidently, the N-SH2 domain does not bind only the PTP domain belonging to the same chain (colored in white), but it also interacts with a number of other protein replicas (colored in blue, purple, green and pink). Specifically, the pY, EF, and BG loops, which would be solvent-exposed under physiological conditions, are in contact with other chains. Hence, the conformations of these loops are likely influenced by such interactions, and not exclusively by the binding of the PTP domain on the other face of N-SH2.</p><fig id="fig4" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Fig. 4.</label><caption hwp:id="caption-5"><p hwp:id="p-27">(A) Cartoon representation of the surrounding of the N-SH2 domain in the crystal structure of autoinhibited SHP2 (pdbID 4DGP (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-6" hwp:rel-id="ref-16">16</xref>)). PTP domain belonging to the same protein chain is colored in white. Other protein replicas, interacting with the central N-SH2 domain (colored in tan), are depicted respectively in blue, purple, green and pink. (B) Correlation between the N-SH2 binding cleft opening, <italic toggle="yes">d</italic><sub>cleft</sub> (Gly<sup>67</sup> C<sub>α</sub>– Lys<sup>89</sup> C<sub>α</sub> distance) and the N- SH2 blocking loop distance from the catalytic PTP loop, <italic toggle="yes">d</italic><sub>block</sub> (Asp<sup>61</sup> C<sub>α</sub>–Ala<sup>460</sup> C<sub>α</sub> distance), as taken from crystal structures of autoinhibited SHP2, comprising either wild type or functional mutants (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-7" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-17" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-3" hwp:rel-id="ref-49">49</xref>, <xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-3" hwp:rel-id="ref-50">50</xref>).</p></caption><graphic xlink:href="388447v3_fig4" position="float" orientation="portrait" hwp:id="graphic-5"/></fig><p hwp:id="p-28">In particular, the Lys<sup>91</sup> side chain in BG loop forms salt bridges with charged residues of another replica, whereas the motion of the Tyr<sup>66</sup> side chain in EF loop is sterically hindered by the presence of other bulky side chains. Even the pY loop, which in absence of a phosphate group is typically modelled in a partially closed conformation, corresponding to an intermediate conformation between the <italic toggle="yes">α</italic>- and <italic toggle="yes">β</italic>-state (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-2" hwp:rel-id="ref-43">43</xref>), interacts with acidic side chains of Glu<sup>313</sup> and Glu<sup>348</sup> belonging to another protein chain. Therefore, the partially closed loops in the N-SH2 domain might have been stabilized by crystal contacts.</p></sec><sec id="s1d" hwp:id="sec-6"><label>D.</label><title hwp:id="title-7">Crystal packing in autoinhibited SHP2 hinders the N-SH2 motions</title><p hwp:id="p-29">According to the “allosteric switch” model, opening of the binding cleft would drive the release of N-SH2 from the PTP domain. Hence, a positive correlation in crystal structures might be expected between (i) cleft opening, given by the Gly<sup>67</sup> C<sub>α</sub>–Lys<sup>89</sup> C<sub>α</sub> distance <italic toggle="yes">d</italic><sub>cleft</sub>, and (ii) release of the DE blocking loop from the catalytic PTP loop, given by the Asp<sup>61</sup> C<sub>α</sub>–Ala<sup>460</sup> C<sub>α</sub> distance <italic toggle="yes">d</italic><sub>block</sub>. On the other hand, according to the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model, a positive correlation might be expected between the opening of the central <italic toggle="yes">β</italic>-sheet and the distance <italic toggle="yes">d</italic><sub>block</sub>. However, despite a significant spread of <italic toggle="yes">d</italic><sub>block</sub> in available crystal structures of autoinhibited SHP2, no such correlation exists. For instance, <italic toggle="yes">d</italic><sub>cleft</sub> and <italic toggle="yes">d</italic><sub>block</sub> are even (poorly) anticorrelated (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig. 4B</xref>), in disagreement with the expectation from the “allosteric switch” model. Also, the spread of the N-SH2 central <italic toggle="yes">β</italic>-sheet lacks the correlation with <italic toggle="yes">d</italic><sub>block</sub> (<italic toggle="yes">SI Appendix</italic>, Fig. S2).</p><p hwp:id="p-30">These data further indicate that crystal packing largely hinders conformational motions of N-SH2 in autoinhibited SHP2 involved in SHP2 activation, and correlations cannot be detected irrespective on the activation mechanism proposed. Hence, (i) to fully resolve the effect of crystal packing on N-SH2 dynamics, and (ii) to quantify the influence of N-SH2 dynamics on SHP2 activation, we employed MD simulations in solution and in a crystal.</p></sec><sec id="s1e" hwp:id="sec-7"><label>E.</label><title hwp:id="title-8">The N-SH2 domain binding cleft is constitutively flexible</title><p hwp:id="p-31">According to the “allosteric switch” model, the opening and the closure of the N-SH2 binding cleft is coupled with SHP2 activation or with stabilization of autoinhibited SHP2 (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-18" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-10" hwp:rel-id="ref-39">39</xref>). Considering that the activation of SHP2 presumably involves a free energy difference of several tens of kJ/mol (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-4" hwp:rel-id="ref-41">41</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-3" hwp:rel-id="ref-43">43</xref>), it is mandatory to evaluate the energy required to open the binding cleft in different conditions.</p><p hwp:id="p-32">In order to quantify the intrinsic flexibility of the binding cleft, we used umbrella sampling to compute the potential of mean force (PMF, also referred to as ‘free energy profile’) of the binding cleft opening for the isolated N-SH2 domain (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Fig. 5 A</xref> and <xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-2" hwp:rel-id="F5">B</xref>). As reaction coordinate, we used the distance <italic toggle="yes">d</italic><sub>cleft</sub> defined as the C<sub>α</sub>–C<sub>α</sub> distance between Gly<sup>67</sup> (belonging to the EG loop) and Lys<sup>89</sup> (belonging to the BG loop). The PMF covers conformations of a completely inaccessible cleft (<italic toggle="yes">d</italic><sub>cleft</sub> = 5 Å, <xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-3" hwp:rel-id="F5">Fig. 5A</xref> cyan cartoon) up to a wide open cleft (<italic toggle="yes">d</italic><sub>cleft</sub> = 14 Å, <xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-4" hwp:rel-id="F5">Fig. 5A</xref> purple cartoon). In <xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-5" hwp:rel-id="F5">Fig. 5B</xref>, the PMF shows a single free energy minimum at ∼11 Å corresponding to an open cleft, in line with the 1AYD crystal structure of apo N-SH2 (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-5" hwp:rel-id="ref-34">34</xref>). This finding is further supported by previous MD simulations of isolated N-SH2 (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-4" hwp:rel-id="ref-43">43</xref>), thereby clearly confirming that the cleft is open in the isolated N-SH2 domain.</p><fig id="fig5" position="float" fig-type="figure" orientation="portrait" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2 xref-fig-5-3 xref-fig-5-4 xref-fig-5-5 xref-fig-5-6 xref-fig-5-7 xref-fig-5-8 xref-fig-5-9 xref-fig-5-10 xref-fig-5-11 xref-fig-5-12 xref-fig-5-13"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Fig. 5.</label><caption hwp:id="caption-6"><p hwp:id="p-33">(A) Simulation snapshot of the N-SH2 domain in water with the binding cleft either closed (cyan cartoon) or open (purple cartoon). Water is not shown for clarity. (B) Potential of mean force (PMF) of the binding cleft opening, <italic toggle="yes">d</italic><sub>cleft</sub>, for the N-SH2 domain in water. Black dots indicate the degree of cleft opening found in various crystal structures. (C) Simulation snapshot of of autoinhibited SHP2 in water with the binding cleft either closed (cyan cartoon) or open (purple cartoon). C-SH2 and PTP domains are shown as orange and pink cartoon, respectively. Water is not shown for clarity. (D) PMF of the binding cleft opening, <italic toggle="yes">d</italic><sub>cleft</sub>, for autoinhibited SHP2 in water. (E) Simulation system of SHP2 in the crystallographic quadruple unit cell of the 4DGP structure. The systems contains 16 SHP2 copies shown in different colors and water shown as red/white sticks. Some crystal contacts in this structure are shown in <xref ref-type="fig" rid="fig4" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig. 4</xref>. (F) PMF of the binding cleft opening, <italic toggle="yes">d</italic><sub>cleft</sub>, for autoinhibited SHP2 in the crystal environment of panel E.</p></caption><graphic xlink:href="388447v3_fig5" position="float" orientation="portrait" hwp:id="graphic-6"/></fig><p hwp:id="p-34">Notably, the PMF further shows that the binding cleft is highly responsive to external perturbations, as only a small energy of 6–10 kJ/mol is required to close the binding cleft into a configuration found in crystal structures of autoinhibited SHP2 with well-resolved loops (e.g 4DGP.A, 4OHH.A, 5I6V.B, cf. <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-2" hwp:rel-id="F3">Fig. 3</xref>) (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-8" hwp:rel-id="ref-16">16</xref>, <xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-4" hwp:rel-id="ref-49">49</xref>, <xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-4" hwp:rel-id="ref-50">50</xref>). Therefore, the EF and the BG loop lining the N-SH2 binding cleft are constitutively flexible, and the binding cleft rearrangement in isolated N-SH2 requires only a small amount of free energy.</p></sec><sec id="s1f" hwp:id="sec-8"><label>F.</label><title hwp:id="title-9">Binding cleft opening is favored in autoinhibited SHP2 in water</title><p hwp:id="p-35">In order to reveal the effect of the PTP allosteric interaction on the N-SH2 binding cleft, we computed the PMF of the binding cleft opening for SHP2 in water, again along the distance <italic toggle="yes">d</italic><sub>cleft</sub> (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-6" hwp:rel-id="F5">Fig. 5 C</xref> and <xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-7" hwp:rel-id="F5">D</xref>). Critically, for all umbrella windows, the C<sub>α</sub>–C<sub>α</sub> distance <italic toggle="yes">d</italic><sub>block</sub> between Asp<sup>61</sup> (belonging to N-SH2 blocking loop) and Ala<sup>460</sup> (belonging to PTP catalytic loop) fluctuated around 6 Å (<italic toggle="yes">SI Appendix</italic>, Fig. S3), mainly below the experimental distances observed in autoinhibited structures of SHP2 (<xref rid="fig4" ref-type="fig" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Fig. 4B</xref>). Therefore, the N-SH2 domain remained closely bound to PTP throughout calculations, and the final PMF in <xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-8" hwp:rel-id="F5">Fig. 5D</xref> represents the opening of the binding cleft in autoinhibited SHP2.</p><p hwp:id="p-36">Surprisingly, even in tight interaction with PTP, a wide-open binding cleft of N-SH2 corresponds to the free energy minimum (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-9" hwp:rel-id="F5">Fig. 5D</xref>). This result disagrees with the “allosteric switch” model (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-19" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-11" hwp:rel-id="ref-39">39</xref>), which instead expects a closed and inaccessible binding cleft when the N-SH2 is bound to PTP. In addition, the PMF shows that a relatively small amount of free energy of 3–9.5 kJ/mol is required to close the binding cleft towards conformations found in crystal structures (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-10" hwp:rel-id="F5">Fig. 5D</xref>, black dots). This suggests that, on one hand, the binding cleft remains flexible and susceptible to structural rearrangements in case of ligand binding. On the other hand, the energy involved in binding cleft rearrangement is presumably many times smaller than the energy required to destabilize the N-SH2/PTP interface, promoting SHP2 activation. In fact, previous molecular dynamics simulations suggested that the complete displacement of N-SH2 away from the PTP active site requires an energy in the order of 70 kJ/mol (<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-5" hwp:rel-id="ref-41">41</xref>, <xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-5" hwp:rel-id="ref-43">43</xref>). Hence, it is unlikely that rearrangement of the binding cleft is sufficient to drive SHP2 activation.</p><p hwp:id="p-37">Taken together, the PMF shows that (i) even in complex with PTP, the binding cleft of N-SH2 is mostly open and accessible to ligands, and (ii) the binding cleft is not tensed and, therefore, rearrangement of the binding cleft alone is insufficient to drive SHP2 activation.</p></sec><sec id="s1g" hwp:id="sec-9"><label>G.</label><title hwp:id="title-10">Crystal contacts hinder the binding cleft opening</title><p hwp:id="p-38">The PMF of SHP2 in solution suggests that the binding cleft is more open in solution than expected from available crystal structures (previous paragraph). In order to shed light on the origin of these discrepancies, we computed the PMF of binding cleft opening for SHP2 in the crystal environment of the 4DGP structure, for which the loops have been well resolved (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-11" hwp:rel-id="F5">Fig. 5E, cf</xref>. <xref rid="fig3" ref-type="fig" hwp:id="xref-fig-3-3" hwp:rel-id="F3">Fig. 3</xref>). Simulations of a protein in the crystal reveal the influence of the crystal packing on protein structure and dynamics by comparing the results with simulations performed with the same system in solution. Such comparisons are still rare in the literature because researchers are often more interested in the properties of a protein in aqueous solution, corresponding to the most common experimental and physiological conditions (<xref ref-type="bibr" rid="c51" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">51</xref>–<xref ref-type="bibr" rid="c54" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">54</xref>).</p><p hwp:id="p-39">The PMF reveals a clear effect of the crystal environment on the binding cleft conformation (<xref rid="fig5" ref-type="fig" hwp:id="xref-fig-5-12" hwp:rel-id="F5">Fig. 5 D</xref> and <xref ref-type="fig" rid="fig5" hwp:id="xref-fig-5-13" hwp:rel-id="F5">F</xref>). Namely, the most stable conformation in the crystal corresponds more closely to the crystal structure with a closed binding cleft (i.e. 4DGP) (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-9" hwp:rel-id="ref-16">16</xref>), whereas the binding cleft opening is strongly hindered. Hence, the tendency of the binding cleft to adopt a closed and inaccessible conformation in crystal structures is likely a bias due to the crystal contacts between protein replicas, and not a consequence of an allosteric mechanism imposed by N-SH2 binding to the PTP active site.</p></sec><sec id="s1h" hwp:id="sec-10"><label>H.</label><title hwp:id="title-11">Binding cleft opening does not promote the activation of SHP2</title><p hwp:id="p-40">Based on the observation that the closed binding cleft is found in crystal structures in correspondence of the autoin-hibited SHP2, whereas the crystal structures of the isolated, peptide-bound N-SH2 exhibited a full open, accessible binding cleft, it was hypothesized that the EF loop, together with the BG loop, may serve as allosteric switch in SHP2 activation (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-20" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-12" hwp:rel-id="ref-39">39</xref>). According to the “allosteric switch” model, the interaction with the PTP active site forces the N-SH2 binding cleft into a closed, inaccessible conformation that prevents ligand binding (switch off); binding of a phosphopeptide would push the N-SH2 binding cleft towards an open, fully accessible conformation, with the consequence of weakening the interactions between the blocking loop and the catalytic site, promoting the N-SH2 domain release from PTP (switch on) (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-21" hwp:rel-id="ref-37">37</xref>, <xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-13" hwp:rel-id="ref-39">39</xref>).</p><p hwp:id="p-41">To definitely test such a model, we used umbrella sampling to compute the PMF for a critical step of SHP2 activation, that is, the release of the N-SH2 domain from the PTP active site, with the N-SH2 binding cleft restrained either in closed (switch off) or in open (switch on) conformation (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Fig. 6</xref>). As reaction coordinate for SHP2 activation, we used the center- of-mass distance between the backbone atoms of the blocking loop and the catalytic PTP loop. Upon pulling the simulation system along this coordinate, the N-SH2 domain moved from its position in the autoinhibited state (<italic toggle="yes">SI Appendix</italic>, Fig. S4) to different positions on the PTP surface, thereby exposing the active site to the solvent as required for SHP2 activation (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-2" hwp:rel-id="F6">Fig. 6 A</xref> and <xref ref-type="fig" rid="fig6" hwp:id="xref-fig-6-3" hwp:rel-id="F6">B</xref> and <italic toggle="yes">SI Appendix</italic>, Movie S1). Among independent simulation runs, the final position of N-SH2 differed, suggesting that activating SHP2 may involve different pathways in conformational space (<italic toggle="yes">SI Appendix</italic>, Fig. S5).</p><fig id="fig6" position="float" fig-type="figure" orientation="portrait" hwp:id="F6" hwp:rev-id="xref-fig-6-1 xref-fig-6-2 xref-fig-6-3 xref-fig-6-4 xref-fig-6-5 xref-fig-6-6 xref-fig-6-7 xref-fig-6-8 xref-fig-6-9 xref-fig-6-10"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;388447v3/FIG6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">fig6</object-id><label>Fig. 6.</label><caption hwp:id="caption-7"><p hwp:id="p-42">(A) Exemplary open and active structure of SHP2 as obtained by pulling simulation. The N-SH2 domain (cyan cartoon) moved from its position in the autoinhibited state to a different position relative to the PTP (pink) and C-SH2 domains (orange), leaving the catalytic site (red) solvent-exposed. (B) Accessibility of the PTP catalytic site versus the distance between the blocking loop and the catalytic PTP loop used as reaction coordinate in pulling simulation, defined as the backbone centers-of-mass distance between residues 60–62 and residues 460–462. The N-SH2 binding cleft was restrained either in closed (switch off, yellow dots) or in open (switch on, red dots) conformation. The accessibility of the PTP catalytic site was defined as the ratio of the solvent-accessible surface (SAS) areas of the PTP loop, obtained including or excluding the N-SH2 domain. The probe radius was 2.38 Å corresponding to a phosphate ion. (C) PMFs of SHP2 opening with the N-SH2 binding cleft restrained either in closed (switch off, yellow line) or in open (switch on, red line) conformation. (D) ΔΔ<italic toggle="yes">G</italic> profiles of SHP2 opening, calculated from the difference of the PMFs for “switch on” relative to the “switch off” conformation in panel C (violet line), and, for comparison, for the <italic toggle="yes">α</italic>-state relative to the <italic toggle="yes">β</italic>-state (green line), calculated from PMFs in Ref. 43. Dashed blue line represents the average ΔΔG value of the Δ<italic toggle="yes">G</italic><sub>on</sub> − Δ<italic toggle="yes">G</italic><sub>off</sub> profile.</p></caption><graphic xlink:href="388447v3_fig6" position="float" orientation="portrait" hwp:id="graphic-7"/></fig><p hwp:id="p-43">These final positions do not represent the fully active state of SHP2, which is reached only upon the binding of a bisphosphoryl tyrosine-based activation motif (BTAM) peptide to both the N-SH2 and C-SH2 domain. In fact, the binding of a single phosphopeptide to the N-SH2 domain triggers only a weak activation, since the N-SH2 domain remains in the neighborhood of the catalytic site (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-2" hwp:rel-id="ref-36">36</xref>). Only the binding of another phosphopeptide to C-SH2, connected to the first phosphopeptide by a linker of suitable length (<xref ref-type="bibr" rid="c55" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">55</xref>), drives the complete dissociation of the N-SH2 domain from the catalytic site and, thereby, the full activation (<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-3" hwp:rel-id="ref-36">36</xref>). Hence, the pulling simulations and the PMFs explore early stages of activation but not the complete activation pathway.</p><p hwp:id="p-44">In disagreement with the “allosteric switch” model, the two PMFs for “switch off” (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-4" hwp:rel-id="F6">Fig. 6C</xref>, yellow line) and “switch on” (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-5" hwp:rel-id="F6">Fig. 6C</xref>, red line), are almost identical, demonstrating that a switch of the binding cleft does not drive dissociation of the N-SH2 domain from PTP. The only perceptible, small difference at proximal distances is the slight right-shift of the “switch on” PMF minimum, likely ascribable to the different tilt of the helix <italic toggle="yes">α</italic>B, whose effects have been predicted from crystal structure analysis (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-22" hwp:rel-id="ref-37">37</xref>). However, such perturbations do not further compromise the interface of the complex at larger distances.</p><p hwp:id="p-45">In <xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-6" hwp:rel-id="F6">Fig. 6D</xref> we report the ΔΔ<italic toggle="yes">G</italic> difference between the two profiles (Δ<italic toggle="yes">G</italic><sub>on</sub> − Δ<italic toggle="yes">G</italic><sub>off</sub>). The flat profile (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-7" hwp:rel-id="F6">Fig. 6D</xref>, violet line), whose average is virtually null (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-8" hwp:rel-id="F6">Fig. 6D</xref>, blue dashed line), confirms that the binding cleft conformation alone has virtually no influence on SHP2 activation. To test if instead the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model rationalizes SHP2 activation, ΔΔG profile of activation was previously computed with the N-SH2 domain either restrained in the <italic toggle="yes">α</italic>- or in the <italic toggle="yes">β</italic>-state (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-9" hwp:rel-id="F6">Fig. 6D</xref>, green line) (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-6" hwp:rel-id="ref-43">43</xref>). Evidently, the ΔΔ<italic toggle="yes">G</italic> values become more and more negative as the distance between N-SH2 and PTP increases, demonstrating that the release of N-SH2 is greatly favored by the <italic toggle="yes">α</italic>-state.</p><p hwp:id="p-46">In conclusion, PMFs indicated that the propensity of the N-SH2 domain to release PTP is essentially unresponsive to the conformation adopted by its binding cleft. Instead, the opening of the central <italic toggle="yes">β</italic>-sheet, as adopted by the <italic toggle="yes">α</italic>-state, leads to a larger rearrangement of the N-SH2 shape, therefore promoting SHP2 activation.</p></sec></sec><sec id="s2" hwp:id="sec-11"><label>2.</label><title hwp:id="title-12">Discussion</title><p hwp:id="p-47">The conformational transition of disordered regions, occurring upon ligand binding or chemical modifications, is a recurrent molecular mechanism in protein regulation (<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-2" hwp:rel-id="ref-42">42</xref>, <xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">56</xref>, <xref ref-type="bibr" rid="c57" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">57</xref>), which is why, for a long time, the flexible loops in the binding cleft of N-SH2 have been considered as molecular switches in an allosteric mechanism controlling SHP2 activation (<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-14" hwp:rel-id="ref-39">39</xref>, <xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-3" hwp:rel-id="ref-42">42</xref>). However, in this study we have brought several arguments in opposition to the “allosteric switch” model: <italic toggle="yes">i)</italic> the structural disorder of the N-SH2 loops in crystal structures, <italic toggle="yes">ii)</italic> the constitutive flexibility of the binding cleft in solution, <italic toggle="yes">iii)</italic> the unexpected opening of the binding cleft, occurring even in autoinhibited SHP2 in water, <italic toggle="yes">iv)</italic> the steric hindrance, induced by the crystal contacts, forcing the binding cleft into a closed conformation, and finally <italic toggle="yes">v)</italic> the missing destabilization of the N-SH2/PTP interface upon binding cleft opening.</p><p hwp:id="p-48">Experimental evidence brought up in favor of the “allosteric switch” model stated that <italic toggle="yes">i)</italic> the phosphopeptide binding is generally stronger to the isolated N-SH2 domain than to the N-SH2 domain as part of SHP2 (<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-3" hwp:rel-id="ref-21">21</xref>), <italic toggle="yes">ii)</italic> the mutations destabilizing the N-SH2/PTP interface not only increase the SHP2 basal activity, but also result in a larger phosphopeptide binding affinity, albeit these mutations do not cluster at the N-SH2 binding site and apparently they do not affect the structure of N-SH2 (<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-3" hwp:rel-id="ref-40">40</xref>). Thus, the direct correlation between the basal activity of SHP2 and the ligand binding affinity to N-SH2, seems coherent with the “allosteric switch” model, because an eventual enhancement of the binding cleft opening would consequently promote the ligand binding to N-SH2. However, such experimental evidence would be potentially in agreement with any other allosteric mechanism involving an equilibrium between a stabilizing conformation and any activating conformation of N-SH2, independently on the structural details governing such an equilibrium. As a matter of fact, the assumption of an equilibrium between a stabilizing conformation, blocked by the interaction with PTP, and an activating conformation, induced by the binding of a phosphopeptide, inevitably leads to the conclusion that any weakening of the N-SH2/PTP interaction not only penalizes the stabilizing conformation in autoinhibited SHP2, but also indirectly makes N-SH2 more prone to bind a ligand. Such a conclusion is valid in case of the “allosteric switch” model, as well as for the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model.</p><p hwp:id="p-49">Certain gain-of-function pathogenic mutations in SHP2 do not cluster at the N-SH2/PTP interface, where they could destabilize the N-SH2/PTP interactions, but seem to have more subtle, allosteric effects, since their impact on SHP2 function cannot be rationalized by mere steric effects. A typical example is the Noonan Syndrome (NS)-causing Thr42Ala substitution that replaces a conserved threonine in the central <italic toggle="yes">β</italic>-sheet (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-2" hwp:rel-id="ref-15">15</xref>). Because Thr<sup>42</sup> forms an H-bond with the phosphotyrosine in wild-type N-SH2, one might expect that Thr<sup>42</sup> contributes to the stability of the N-SH2/phosphopeptide complex. However, the substitution with alanine leads to an increase in phosphopeptide binding affinity (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-3" hwp:rel-id="ref-15">15</xref>), as documented by the dramatically enhanced catalytic activity of the SHP2<sup>A42</sup> mutant upon stimulation with a BTAM peptide (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-4" hwp:rel-id="ref-15">15</xref>). Notably, the “allosteric switch” model has been so far unable to convincingly explain the pathogenicity of the Thr42Ala substitution, in terms of either enhancement of the binding cleft opening or formation of additional favorable contacts with the phosphopeptide (<xref ref-type="bibr" rid="c15" hwp:id="xref-ref-15-5" hwp:rel-id="ref-15">15</xref>). Instead, owing to the reduced propensity of alanine for forming <italic toggle="yes">β</italic>-sheets as compared to threonine (<xref ref-type="bibr" rid="c58" hwp:id="xref-ref-58-1" hwp:rel-id="ref-58">58</xref>), the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model attributes to the Thr42Ala substitution the effect of destabilizing the central <italic toggle="yes">β</italic>-sheet, thereby rendering N-SH2 more prone to adopt the activating <italic toggle="yes">α</italic>-state (<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-7" hwp:rel-id="ref-43">43</xref>).</p><p hwp:id="p-50">Analogously to the opening/closure of the binding cleft, the opening and closure of the central <italic toggle="yes">β</italic>-sheet in N-SH2 is detectable by comparing the crystal structures of autoinhibited SHP2 with crystal structures of the isolated N-SH2 domain bound to a phosphopeptide (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-6" hwp:rel-id="ref-34">34</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-23" hwp:rel-id="ref-37">37</xref>). Thus, it does not come as a surprise that the opening of the central <italic toggle="yes">β</italic>-sheet emerges for the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model as the key determinant of the N-SH2 reshaping, which leads to the loss of complementarity for PTP, and thereby to the activation of SHP2. However, according to the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model, a coupling exists between the opening of the central <italic toggle="yes">β</italic>-sheet with both the closure of the pY loop and the tightening of the cleft at the +5 site. Therefore, we can conclude that the role of the binding cleft in N-SH2 is not to directly cause the loss of complementarity for PTP, but to induce, through the recognition and clamping of an activating phosphopeptide, a more extensive, concerted rearrangement in N-SH2 structure, which ends with the central <italic toggle="yes">β</italic>-sheet opening.</p><p hwp:id="p-51">In conclusion, SHP2 is activated by an allosteric mechanism. However, our analysis suggests that the key transition triggering SHP2 activation is not the opening of the N-SH2 binding cleft but instead the opening of the central <italic toggle="yes">β</italic>-sheet of the N-SH2 domain, as captured by the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model. The <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model includes, apart from central <italic toggle="yes">β</italic>-sheet opening, also structural elements that were previously considered by the “allosteric switch” model. As such, the <italic toggle="yes">α</italic>–<italic toggle="yes">β</italic> model can be considered as a generalized formulation of an allosteric mechanism, leading to a better comprehension of the structural transitions governing the activation of SHP2.</p></sec><sec id="s3" hwp:id="sec-12"><title hwp:id="title-13">Materials and Methods</title><sec id="s3a" hwp:id="sec-13"><title hwp:id="title-14">Analyses on crystallographic structures</title><p hwp:id="p-52">Structures of autoinhibited SHP2, in its wild-type form or mutants, were taken from RCSB Protein Data Bank: 2SHP (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-24" hwp:rel-id="ref-37">37</xref>), 4DGP (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-10" hwp:rel-id="ref-16">16</xref>), 4DGX (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-11" hwp:rel-id="ref-16">16</xref>), 4GWF, 4H1O, 4H34, 4NWF, 4NWG, 4OHD (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-5" hwp:rel-id="ref-50">50</xref>), 4OHE (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-6" hwp:rel-id="ref-50">50</xref>), 4OHH (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-7" hwp:rel-id="ref-50">50</xref>), 4OHI (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-8" hwp:rel-id="ref-50">50</xref>), 4OHL (<xref ref-type="bibr" rid="c50" hwp:id="xref-ref-50-9" hwp:rel-id="ref-50">50</xref>), 5I6V (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-5" hwp:rel-id="ref-49">49</xref>), 5IBM (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-6" hwp:rel-id="ref-49">49</xref>), 5IBS (<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-7" hwp:rel-id="ref-49">49</xref>). Dihedral angles were validated using the MolProbity web server (<xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-2" hwp:rel-id="ref-44">44</xref>). Electron densities were inspected with Coot (<xref ref-type="bibr" rid="c59" hwp:id="xref-ref-59-1" hwp:rel-id="ref-59">59</xref>). R-values and Z-scores were obtained from the residue-wise electron density using Uppsala Electron Density Server (<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-5" hwp:rel-id="ref-48">48</xref>).</p></sec><sec id="s3b" hwp:id="sec-14"><label>MD</label><title hwp:id="title-15">simulations of the N-SH2 domain in solution</title><p hwp:id="p-53">The initial atomic coordinates (residues 3–103) were derived from crystallographic structure 1AYD (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-7" hwp:rel-id="ref-34">34</xref>). N-SH2 was put at the center of a dodecahedron box, large enough to contain the domain and at least 0.9 nm of solvent on all sides, and then it was solvated with 5577 explicit TIP3P (<xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-1" hwp:rel-id="ref-60">60</xref>) water molecules.</p><p hwp:id="p-54">MD simulations were performed with the GROMACS software package (<xref ref-type="bibr" rid="c61" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">61</xref>), using the AMBER99SB<sup>*</sup>-ILDNP force field (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">62</xref>, <xref ref-type="bibr" rid="c63" hwp:id="xref-ref-63-1" hwp:rel-id="ref-63">63</xref>) if not stated otherwise. Long-range electrostatic interactions were calculated with the particle-mesh Ewald (PME) approach (<xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-1" hwp:rel-id="ref-64">64</xref>). A cutoff of 1.2 nm was applied to the direct-space Coulomb and Lennard-Jones interactions. Bond lengths and angles of water molecules were constrained with the SETTLE algorithm (<xref ref-type="bibr" rid="c65" hwp:id="xref-ref-65-1" hwp:rel-id="ref-65">65</xref>), and all other bonds were constrained with LINCS (<xref ref-type="bibr" rid="c66" hwp:id="xref-ref-66-1" hwp:rel-id="ref-66">66</xref>). The pressure was set to 1 bar using the Parrinello-Rahman barostat (<xref ref-type="bibr" rid="c67" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">67</xref>). The temperature was controlled at 300 K using velocity-rescaling with a stochastic term (<xref ref-type="bibr" rid="c68" hwp:id="xref-ref-68-1" hwp:rel-id="ref-68">68</xref>).</p><p hwp:id="p-55">The solvent was relaxed by energy minimization followed by 100 ps of MD at 300 K, while restraining protein coordinates with a harmonic potential. The system was then minimized without restraints and its temperature thermalized to 300 K in 10 ns, in a stepwise manner. After an equilibration run of 100 ns while N-SH2 was left completely unrestraint, the protein was equilibrated keeping the binding cleft closed. The C<sub>α</sub> distance between Gly<sup>67</sup> (belonging to the EG loop) and Lys<sup>89</sup> (belonging to the BG loop) was chosen as reaction coordinate for cleft opening, denoted <italic toggle="yes">d</italic><sub>cleft</sub>. An umbrella potential (k = 10000 kJ/mol nm<sup>2</sup>) was progressively introduced in 10 ns, and maintained for other 100 ns, so that the <italic toggle="yes">d</italic><sub>cleft</sub> was finally constrained at 5 Å.</p><p hwp:id="p-56">To maintain the N-SH2 domain with the central <italic toggle="yes">β</italic>-sheet parallel and closed, a flat-bottom potential (k = 10000 kJ/mol nm<sup>2</sup>), was introduced between the carbonyl C atom of Gly<sup>39</sup> and the backbone N atom of Asn<sup>58</sup>, whose equilibrium distance was 4 Å; such a flat-bottom potential, acting only for distances larger than 4.4 Å, remained inactive during most part of the simulations, and it simply prevented the N-SH2 domain, rarely reaching the transition state, from further relaxing in a conformation with the central <italic toggle="yes">β</italic>-sheet completely open.</p><p hwp:id="p-57">The reference distance of <italic toggle="yes">d</italic><sub>cleft</sub> = 7 Å was considered for the closed binding cleft (corresponding to the distance in 2SHP (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-25" hwp:rel-id="ref-37">37</xref>) crystal structure of autoinhibited SHP2), while a reference distance of 12 Å was chosen for the open binding cleft (corresponding to the distance in 1AYA (<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-8" hwp:rel-id="ref-34">34</xref>) crystal structure of N-SH2 complexed with a phosphopeptide). A pulling simulation (<xref ref-type="bibr" rid="c69" hwp:id="xref-ref-69-1" hwp:rel-id="ref-69">69</xref>, <xref ref-type="bibr" rid="c70" hwp:id="xref-ref-70-1" hwp:rel-id="ref-70">70</xref>) was carried out for gradually opening the binding cleft over 180 ns. The pull force constant was set to 1000 kJ mol<sup>-1</sup>nm<sup>-2</sup>, whereas the reference <italic toggle="yes">d</italic><sub>cleft</sub> was gradually increased from 5 to 14 Å with a velocity of 5×10<sup>−6</sup> nm/ps.</p><p hwp:id="p-58">To further improve the conformation sampling during these pulling simulations and to obtain more independent starting frames for umbrella sampling (see below), we coupled the pulling simulations with simulated tempering (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-1" hwp:rel-id="ref-71">71</xref>). In line with previous studies (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-2" hwp:rel-id="ref-71">71</xref>, <xref ref-type="bibr" rid="c72" hwp:id="xref-ref-72-1" hwp:rel-id="ref-72">72</xref>), simulated tempering simulations were carried out at constant volume, and temperature steps of 10 K between 300 and 380 K were applied. Temperature changes were controlled according to the Metropolis algorithm to obtain canonical ensembles at all temperatures. The initial weights were chosen following Park and Pande (<xref ref-type="bibr" rid="c72" hwp:id="xref-ref-72-2" hwp:rel-id="ref-72">72</xref>). Temperature transitions were attempted every 1 ps, and the weights were updated throughout the whole simulation according to the Wang-Landau adaptive weighting scheme (<xref ref-type="bibr" rid="c73" hwp:id="xref-ref-73-1" hwp:rel-id="ref-73">73</xref>).</p><p hwp:id="p-59">The PMFs were obtained by means of umbrella sampling and WHAM (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-1" hwp:rel-id="ref-74">74</xref>, <xref ref-type="bibr" rid="c75" hwp:id="xref-ref-75-1" hwp:rel-id="ref-75">75</xref>), using 46 windows, equispaced by 0.2 Å. Initial configurations for umbrella sampling were taken from the previous simulated tempering pulling simulations by means of a cluster analysis, thereby ensuring that the umbrella simulations were triggered from the most representative conformations. Accordingly, the configurations were collected from the sub-ensemble at 300 K, divided in 46 groups on the base of the umbrella window interval they belong, and clustered using the GROMOS clustering method (<xref ref-type="bibr" rid="c76" hwp:id="xref-ref-76-1" hwp:rel-id="ref-76">76</xref>). The clustering cutoff was chosen on the base of the root mean-square deviation distribution in each group, picking the value corresponding to the first relative maximum along the abscissa. The umbrella force constant was set to 1000 kJ mol<sup>-1</sup>nm<sup>-2</sup>, and a sampling of 1.5 <italic toggle="yes">µ</italic>s was performed for each window. Statistical errors of the PMFs were estimated with the Bayesian bootstrap of complete histograms (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-2" hwp:rel-id="ref-74">74</xref>), thereby considering only complete histograms as independent, yielding a maximum error of less than 2 kJ/mol.</p></sec><sec id="s3c" hwp:id="sec-15"><label>MD</label><title hwp:id="title-16">simulations of SHP2 in solution</title><p hwp:id="p-60">The initial coordinates of SHP2 were taken from the autoinhibited conformation (2SHP) (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-26" hwp:rel-id="ref-37">37</xref>). The protein was positioned at the center of a dodecahedral box, large enough to contain the protein and at least 0.9 nm of solvent on all sides, and solvated with ∼23,000 explicit water molecules (<xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-2" hwp:rel-id="ref-60">60</xref>) and three Na<sup>+</sup> ions. The structure was minimized and thermalized to 300 K using the procedure described above for N-SH2. A simulation of 1 <italic toggle="yes">µ</italic>s was performed to ensure a well-equilibrated autoinhibited structure in solution.</p><p hwp:id="p-61">Next, the protein was equilibrated maintaining the binding cleft respectively either closed or open. An umbrella potential on <italic toggle="yes">d</italic><sub>cleft</sub> (k = 10000 kJ/mol nm<sup>2</sup>) was progressively introduced within 100 ns, and maintained for other 100 ns, so that <italic toggle="yes">d</italic><sub>cleft</sub> was finally constrained either at 5 Å or at 14 Å. The procedure was repeated four times providing the same number of independent equilibrated configurations of SHP2 with the N-SH2 binding cleft either in closed or in open conformation. To avoid the opening of the central <italic toggle="yes">β</italic>- sheet in the N-SH2 domain, a flat-bottom potential was applied as described above.</p><p hwp:id="p-62">Four pulling simulations were spawned either for gradually opening or for closing the binding cleft over 180 ns (eight simulations in total). The pull force constant was set to 1000 kJ mol<sup>-1</sup>nm<sup>-2</sup>, whereas the reference <italic toggle="yes">d</italic><sub>cleft</sub> was changed with a velocity of 5×10<sup>−6</sup> nm/ps. Simulated tempering (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-3" hwp:rel-id="ref-71">71</xref>) was used to enhance sampling, using a temperature range from 300 to 380 K in steps of 5 K. In order to avoid the premature activation of SHP2 at higher temperatures and to maintain its autoinhibited structure, a flat-bottom potential (k = 10000 kJ/mol nm<sup>2</sup>), was introduced between the C<sub>α</sub> atom of Asp<sup>61</sup> (belonging to the N-SH2 blocking loop) and the C<sub>α</sub> atom of Ala<sup>460</sup> (belonging to PTP catalytic loop); this flat-bottom potential, only acting when the distance <italic toggle="yes">d</italic><sub>block</sub> was larger than 6.4 Å, was removed after the end of the simulated tempering pulling simulations. The PMF along <italic toggle="yes">d</italic><sub>cleft</sub> was computed as described above, except that each umbrella window was simulated for 250 ns.</p></sec><sec id="s3d" hwp:id="sec-16"><label>MD</label><title hwp:id="title-17">simulations of SHP2 in crystal environment</title><p hwp:id="p-63">The initial coordinates of SHP2 were taken from the autoinhibited conformation (4DGP) (<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-12" hwp:rel-id="ref-16">16</xref>). This SHP2 crystal, which belongs to the P2<sub>1</sub>2<sub>1</sub>2 space group containing four symmetry-related molecules, has the following orthorhombic unit cell parameters: a = 5.485 nm, b = 22.110 nm, c = 4.036 nm, and <italic toggle="yes">α</italic> = <italic toggle="yes">β</italic> = <italic toggle="yes">γ</italic> = 90°. Missing or incomplete residues (strands Leu<sup>236</sup>–Gln<sup>245</sup>, Gly<sup>295</sup>–Val<sup>301</sup>, Phe<sup>314</sup>–Pro<sup>323</sup>, residues Met<sup>1</sup>, Thr<sup>2</sup>, Lys<sup>235</sup>, Arg<sup>527</sup>, Arg<sup>528</sup> and the His-tagged tail Leu<sup>529</sup>– His<sup>536</sup>) were modelled by MOE (<xref ref-type="bibr" rid="c77" hwp:id="xref-ref-77-1" hwp:rel-id="ref-77">77</xref>) using the AMBER12:EHT force field and enabling the periodic system for P2<sub>1</sub>2<sub>1</sub>2 space group. The starting coordinates of the single crystal unit cell were obtained by applying the P2<sub>1</sub>2<sub>1</sub>2 symmetry transformation. Next, the quadruple unit cell was generated by shifting the entire box along the <italic toggle="yes">x</italic> axis and/or <italic toggle="yes">z</italic> axis, resulting in an orthorhombic simulation box, with edges of 10.970 nm, 22.110 nm, and 8.072 nm, containing 16 protein molecules. We used multiple unit cells as simulation box to fully exclude spurious couplings between the motion of the protein and its periodic images and to exclude unrealistic long-range correlations.</p><p hwp:id="p-64">The AMBER99SB<sup>*</sup>-ILDNP force field (<xref ref-type="bibr" rid="c62" hwp:id="xref-ref-62-2" hwp:rel-id="ref-62">62</xref>, <xref ref-type="bibr" rid="c63" hwp:id="xref-ref-63-2" hwp:rel-id="ref-63">63</xref>) was used, while a flat-bottom potential (k = 10000 kJ/mol nm<sup>2</sup>), was introduced between the carbonyl C atom of Gly<sup>39</sup> and the backbone N atom of Asn<sup>58</sup>. The system was solvated with 26908 explicit water molecules (<xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-3" hwp:rel-id="ref-60">60</xref>) and 32 Na<sup>+</sup> ions. The solvent box was generated by two successive solvent additions, each followed by a solvent relaxation session. The solvent was relaxed by energy minimization followed by 100 ps MD at 300 K, while restraining protein positions with a harmonic potential. The system was then energy-minimized without restraints and its temperature brought in a stepwise manner to 300 K in 10 ns.</p><p hwp:id="p-65">In order to remove the conformational correlation between protein replicas, an equilibration run of 50 ns at 300 K was performed, followed by 50 ns of simulated tempering (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-4" hwp:rel-id="ref-71">71</xref>), with temperature ranging from 300 to 360 K in steps of 2 K, and another equilibration run of 50 ns.</p><p hwp:id="p-66">Starting from the last system structure, two pulling simulations were spawned either for gradually opening or for gradually closing the binding cleft in each of the 16 protein replicas (32 simulations in total). The pull force constant was set to 1000 kJ mol<sup>-1</sup>nm<sup>-2</sup>, whereas the reference <italic toggle="yes">d</italic><sub>cleft</sub> was changed with a velocity of 5×10<sup>−6</sup> nm/ps. Simulated tempering (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-5" hwp:rel-id="ref-71">71</xref>) was used to enhance sampling, using a temperature range from 300 to 360 K in steps of 2 K. Again, a flat-bottomed potential was used to avoid the opening of the central <italic toggle="yes">β</italic>-sheet, and immediately removed after the end of the simulated tempering pulling simulations. The PMF along <italic toggle="yes">d</italic><sub>cleft</sub> was computed as described above, except that each umbrella window was simulated for 20 ns.</p></sec><sec id="s3e" hwp:id="sec-17"><label>MD</label><title hwp:id="title-18">simulations of the activation of SHP2, with the binding cleft restrained into the closed or open conformation</title><p hwp:id="p-67">The initial coordinates of SHP2 were taken from the autoinhibited conformation (2SHP) (<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-27" hwp:rel-id="ref-37">37</xref>). The protein was positioned at the center of a dodecahedral box, and solvated with ∼23,000 explicit water molecules (<xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-4" hwp:rel-id="ref-60">60</xref>) and three Na<sup>+</sup> ions. Because certain Amber force fields in conjunction with TIP3P have been reported to overstabilize protein-protein contacts (<xref ref-type="bibr" rid="c78" hwp:id="xref-ref-78-1" hwp:rel-id="ref-78">78</xref>), we used the CHARMM36m force field (<xref ref-type="bibr" rid="c79" hwp:id="xref-ref-79-1" hwp:rel-id="ref-79">79</xref>) for simulations of SHP2 activation. Hydrogen atoms were described as virtual sites, allowing a time step of 4 fs. The structure was minimized and thermalized to 300 K using the procedure described above. A simulation of 1 <italic toggle="yes">µ</italic>s was performed to ensure a well-equilibrated autoinhibited structure in solution.</p><p hwp:id="p-68">Next, the binding cleft of the N-SH2 domain was restrained either in closed (<italic toggle="yes">d</italic><sub>cleft</sub> = 5 Å) or in open conformation (<italic toggle="yes">d</italic><sub>cleft</sub> = 12 Å), using a harmonic restraint along <italic toggle="yes">d</italic><sub>cleft</sub> (k = 1000 kJ/mol nm<sup>2</sup>). Opening of the central <italic toggle="yes">β</italic>-sheet was excluded using a flat-bottomed potential, as described above. N-SH2 was pulled away from PTP using 600 ns pulling simulations at constant pull velocity (<xref ref-type="bibr" rid="c69" hwp:id="xref-ref-69-2" hwp:rel-id="ref-69">69</xref>). The center-of-mass distance between the backbone atoms of the blocking loop (residues 60–62) and the catalytic PTP loop (residues 460–462) was chosen as reaction coordinate. That distance was pulled from 0.73 nm to 2.15 nm. To obtain statistically independent pathways for SHP2 opening, eight pulling simulations were carried out for each N-SH2 binding cleft state, restrained either in closed or in open conformation (16 simulations in total). To further improve the conformation sampling, we coupled the pulling simulations with simulated tempering (<xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-6" hwp:rel-id="ref-71">71</xref>), using a temperature range from 300 to 400 K in steps of 5 K.</p><p hwp:id="p-69">The PMFs for the opening of SHP2 were obtained using umbrella sampling and the weighted histogram analysis method (WHAM) (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-3" hwp:rel-id="ref-74">74</xref>, <xref ref-type="bibr" rid="c75" hwp:id="xref-ref-75-2" hwp:rel-id="ref-75">75</xref>). Two PMFs were computed with the N-SH2 binding cleft restrained either in closed or in open conformation. For each profile, 72 windows, equispaced by 0.2 Å, were used. Initial configurations for umbrella sampling were taken from the previous simulated tempering pulling simulations by means of a cluster analysis (<xref ref-type="bibr" rid="c76" hwp:id="xref-ref-76-2" hwp:rel-id="ref-76">76</xref>). Because breaking of N-SH2/PTP contacts involves larger forces, we used an increased umbrella force constant was set to 4000 kJ mol<sup>-1</sup>nm<sup>-2</sup>. Each window was sampled for 100 ns. Statistical errors of the PMFs were estimated using the Bayesian bootstrap of complete histograms (<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-4" hwp:rel-id="ref-74">74</xref>).</p><p hwp:id="p-70">The normalized SAS of the PTP loop (<xref rid="fig6" ref-type="fig" hwp:id="xref-fig-6-10" hwp:rel-id="F6">Fig. 6B</xref>) was defined as <italic toggle="yes">A/A</italic><sub>max</sub>, where <italic toggle="yes">A</italic> denotes the the SAS computed from the MD frame, and <italic toggle="yes">A</italic><sub>max</sub> the SAS from the same MD frame after removing the N-SH2 domain.</p></sec></sec><sec sec-type="supplementary-material" hwp:id="sec-18"><title hwp:id="title-19">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Supporting information</label><media xlink:href="supplements/388447_file03.zip" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-20">ACKNOWLEDGMENTS</title><p hwp:id="p-71">This study has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement MARS n. 705829 and from the Deutsche Forschungsgemeinschaft (grant no HU 1971-3/1).</p></ack><ref-list hwp:id="ref-list-1"><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Tajan M"><given-names>M</given-names> <surname>Tajan</surname></string-name>, <string-name name-style="western" hwp:sortable="de Rocca Serra A"><given-names>A</given-names> <surname>de Rocca Serra</surname></string-name>, <string-name name-style="western" hwp:sortable="P Valet T"><surname>P Valet</surname>, <given-names>T</given-names></string-name> <string-name name-style="western" hwp:sortable="Edouard Yart"><surname>Edouard</surname>, <given-names>Yart</given-names></string-name>, <article-title hwp:id="article-title-2">SHP2 sails from physiology to pathology</article-title>. <source hwp:id="source-1">Eur. J. Med. Genet</source>. <volume>58</volume>, <fpage>509</fpage>–<lpage>525</lpage> (<year>2015</year>).</citation></ref><ref id="c2" hwp:id="ref-2"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Dance M"><given-names>M</given-names> <surname>Dance</surname></string-name>, <string-name name-style="western" hwp:sortable="Montagner A"><given-names>A</given-names> <surname>Montagner</surname></string-name>, <string-name name-style="western" hwp:sortable="Salles JP"><given-names>JP</given-names> <surname>Salles</surname></string-name>, <string-name name-style="western" hwp:sortable="Yart A"><given-names>A</given-names> <surname>Yart</surname></string-name>, <string-name name-style="western" hwp:sortable="Raynal P"><given-names>P</given-names> <surname>Raynal</surname></string-name>, <article-title hwp:id="article-title-3">The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway</article-title>. <source hwp:id="source-2">Cell Signal</source> <volume>20</volume>, <fpage>453</fpage>–<lpage>459</lpage> (<year>2008</year>).</citation></ref><ref id="c3" hwp:id="ref-3"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Shen D"><given-names>D</given-names> <surname>Shen</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-4">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers</article-title>. <source hwp:id="source-3">Eur J Med Chem</source> <volume>190</volume>, <fpage>112117</fpage> (<year>2020</year>).</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Tang K"><given-names>K</given-names> <surname>Tang</surname></string-name>, <string-name name-style="western" hwp:sortable="Jia YN"><given-names>YN</given-names> <surname>Jia</surname></string-name>, <string-name name-style="western" hwp:sortable="Yu B"><given-names>B</given-names> <surname>Yu</surname></string-name>, <string-name name-style="western" hwp:sortable="Liu HM"><given-names>HM</given-names> <surname>Liu</surname></string-name>, <article-title hwp:id="article-title-5">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders</article-title>. <source hwp:id="source-4">Eur J Med Chem</source> <volume>204</volume>, <fpage>112657</fpage> (<year>2020</year>).</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Li SM"><given-names>SM</given-names> <surname>Li</surname></string-name>, <article-title hwp:id="article-title-6">The biological function of SHP2 in human disease</article-title>. <source hwp:id="source-5">Mol Biol (Mosk)</source> <volume>50</volume>, <fpage>27</fpage>–<lpage>33</lpage> (<year>2016</year>).</citation></ref><ref id="c6" hwp:id="ref-6"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Digilio MC"><given-names>MC</given-names> <surname>Digilio</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-7">Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene</article-title>. <source hwp:id="source-6">Am J Hum Genet</source>. <volume>71</volume>, <fpage>389</fpage>–<lpage>394</lpage> (<year>2002</year>).</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Tartaglia &gt;M"><given-names>&gt;M</given-names> <surname>Tartaglia</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-8">Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease</article-title>. <source hwp:id="source-7">Am J Hum Genet</source>. <volume>78</volume>, <fpage>279</fpage>–<lpage>290</lpage> (<year>2006</year>).</citation></ref><ref id="c8" hwp:id="ref-8"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Tartaglia M"><given-names>M</given-names> <surname>Tartaglia</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-9">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</article-title>. <source hwp:id="source-8">Nat Genet</source>. <volume>29</volume>, <fpage>465</fpage>–<lpage>468</lpage> (<year>2001</year>).</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1 xref-ref-9-2"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Keilhack H"><given-names>H</given-names> <surname>Keilhack</surname></string-name>, <string-name name-style="western" hwp:sortable="David FS"><given-names>FS</given-names> <surname>David</surname></string-name>, <string-name name-style="western" hwp:sortable="McGregor M"><given-names>M</given-names> <surname>McGregor</surname></string-name>, <string-name name-style="western" hwp:sortable="Cantley LC"><given-names>LC</given-names> <surname>Cantley</surname></string-name>, <string-name name-style="western" hwp:sortable="Neel BG"><given-names>BG</given-names> <surname>Neel</surname></string-name>, <article-title hwp:id="article-title-10">Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes</article-title>. <source hwp:id="source-9">J Biol Chem</source> <volume>280</volume>, <fpage>30984</fpage>–<lpage>30993</lpage> (<year>2005</year>).</citation></ref><ref id="c10" hwp:id="ref-10"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Qiu W"><given-names>W</given-names> <surname>Qiu</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-11">Structural insights into Noonan/LEOPARD syndrome-related mutants of proteintyrosine phosphatase SHP2 (PTPN11)</article-title>. <source hwp:id="source-10">BMC Struct Biol</source> <volume>14</volume>, <fpage>10</fpage> (<year>2014</year>).</citation></ref><ref id="c11" hwp:id="ref-11"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Martinelli S"><given-names>S</given-names> <surname>Martinelli</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-12">Counteracting effects operating on Src homology 2 domain-containing protein-tyrosine phosphatase 2 (SHP2) function drive selection of the recurrent Y62D and Y63C substitutions in Noonan syndrome</article-title>. <source hwp:id="source-11">J Biol Chem</source> <volume>287</volume>, <fpage>27066</fpage>–<lpage>27077</lpage> (<year>2012</year>).</citation></ref><ref id="c12" hwp:id="ref-12"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Edouard T"><given-names>T</given-names> <surname>Edouard</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-13">Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signaling</article-title>. <source hwp:id="source-12">Mol Cell Biol</source> <volume>30</volume>, <fpage>2498</fpage>–<lpage>2507</lpage> (<year>2010</year>).</citation></ref><ref id="c13" hwp:id="ref-13"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Hanna N"><given-names>N</given-names> <surname>Hanna</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-14">Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1</article-title>. <source hwp:id="source-13">FEBS Lett</source> <volume>580</volume>, <fpage>2477</fpage>–<lpage>2482</lpage> (<year>2006</year>).</citation></ref><ref id="c14" hwp:id="ref-14"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Kontaridis MI"><given-names>MI</given-names> <surname>Kontaridis</surname></string-name>, <string-name name-style="western" hwp:sortable="Swanson KD"><given-names>KD</given-names> <surname>Swanson</surname></string-name>, <string-name name-style="western" hwp:sortable="David FS"><given-names>FS</given-names> <surname>David</surname></string-name>, D Barford, <string-name name-style="western" hwp:sortable="Neel BG"><given-names>BG</given-names> <surname>Neel</surname></string-name>, <article-title hwp:id="article-title-15">PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects</article-title>. <source hwp:id="source-14">J Biol Chem</source> <volume>281</volume>, <fpage>6785</fpage>– <lpage>6792</lpage> (<year>2006</year>).</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1 xref-ref-15-2 xref-ref-15-3 xref-ref-15-4 xref-ref-15-5"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Martinelli S"><given-names>S</given-names> <surname>Martinelli</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-16">Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes</article-title>. <source hwp:id="source-15">Hum Mol Genet</source>. <volume>17</volume>, <fpage>2018</fpage>–<lpage>2029</lpage> (<year>2008</year>).</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1 xref-ref-16-2 xref-ref-16-3 xref-ref-16-4 xref-ref-16-5 xref-ref-16-6 xref-ref-16-7 xref-ref-16-8 xref-ref-16-9 xref-ref-16-10 xref-ref-16-11 xref-ref-16-12"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Yu ZH"><given-names>ZH</given-names> <surname>Yu</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-17">Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations</article-title>. <source hwp:id="source-16">J Biol Chem</source> <volume>288</volume>, <fpage>10472</fpage>–<lpage>10482</lpage> (<year>2013</year>).</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Ahmed TA"><given-names>TA</given-names> <surname>Ahmed</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-18">SHP2 drives adaptive resistance to ERK signaling inhibition in molecularly defined subsets of ERK-dependent tumors</article-title>. <source hwp:id="source-17">Cell Reports</source> <volume>26</volume>, <fpage>65</fpage>–<lpage>78</lpage>.e5 (<year>2019</year>).</citation></ref><ref id="c18" hwp:id="ref-18"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Butterworth S"><given-names>S</given-names> <surname>Butterworth</surname></string-name>, <string-name name-style="western" hwp:sortable="Overduin M"><given-names>M</given-names> <surname>Overduin</surname></string-name>, <string-name name-style="western" hwp:sortable="Barr AJ"><given-names>AJ</given-names> <surname>Barr</surname></string-name>, <article-title hwp:id="article-title-19">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</article-title>. <source hwp:id="source-18">Futur. Medicinal Chem</source>. <volume>6</volume>, <fpage>1423</fpage>–<lpage>1437</lpage> (<year>2014</year>).</citation></ref><ref id="c19" hwp:id="ref-19"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Chen YN"><given-names>YN</given-names> <surname>Chen</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-20">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</article-title>. <source hwp:id="source-19">Nature</source> <volume>535</volume>, <fpage>148</fpage>–<lpage>152</lpage> (<year>2016</year>).</citation></ref><ref id="c20" hwp:id="ref-20"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Frankson R"><given-names>R</given-names> <surname>Frankson</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-21">Therapeutic targeting of oncogenic tyrosine phosphatases</article-title>. <source hwp:id="source-20">Cancer Res</source>. <volume>77</volume>, <fpage>5701</fpage> (<year>2017</year>).</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1 xref-ref-21-2 xref-ref-21-3"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Hayashi T"><given-names>T</given-names> <surname>Hayashi</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-22">Differential mechanisms for SHP2 binding and activation are exploited by geographically distinct Helicobacter pylori CagA oncoproteins</article-title>. <source hwp:id="source-21">Cell Rep</source> <volume>20</volume>, <fpage>2876</fpage>–<lpage>2890</lpage> (<year>2017</year>).</citation></ref><ref id="c22" hwp:id="ref-22"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Hui E"><given-names>E</given-names> <surname>Hui</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-23">T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition</article-title>. <source hwp:id="source-22">Science</source> <volume>355</volume>, <fpage>1428</fpage>–<lpage>1433</lpage> (<year>2017</year>).</citation></ref><ref id="c23" hwp:id="ref-23"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Prahallad A"><given-names>A</given-names> <surname>Prahallad</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-24">PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs</article-title>. <source hwp:id="source-23">Cell Re</source> <volume>12</volume>, <fpage>1978</fpage>–<lpage>1985</lpage> (<year>2015</year>).</citation></ref><ref id="c24" hwp:id="ref-24"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Ran H"><given-names>H</given-names> <surname>Ran</surname></string-name>, <string-name name-style="western" hwp:sortable="Tsutsumi R"><given-names>R</given-names> <surname>Tsutsumi</surname></string-name>, <string-name name-style="western" hwp:sortable="Araki T"><given-names>T</given-names> <surname>Araki</surname></string-name>, <string-name name-style="western" hwp:sortable="Neel BG"><given-names>BG</given-names> <surname>Neel</surname></string-name>, <article-title hwp:id="article-title-25">Sticking it to cancer with molecular glue for SHP2</article-title>. <source hwp:id="source-24">Cancer Cell</source> <volume>30</volume>, <fpage>194</fpage>–<lpage>196</lpage> (<year>2016</year>).</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Torres-Ayuso P"><given-names>P</given-names> <surname>Torres-Ayuso</surname></string-name>, <article-title hwp:id="article-title-26">J Brognard, Shipping out MEK inhibitor resistance with SHP2 inhibitors</article-title>. <source hwp:id="source-25">Cancer Discov</source> <volume>8</volume>, <fpage>1210</fpage>–<lpage>1212</lpage> (<year>2018</year>).</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Tartaglia M"><given-names>M</given-names> <surname>Tartaglia</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-27">Somatic PTPN11 mutations in childhood acute myeloid leukaemia</article-title>. <source hwp:id="source-26">Br J Haematol</source> <volume>129</volume>, <fpage>333</fpage>–<lpage>339</lpage> (<year>2005</year>).</citation></ref><ref id="c27" hwp:id="ref-27"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Tartaglia M"><given-names>M</given-names> <surname>Tartaglia</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-28">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</article-title>. <source hwp:id="source-27">Blood</source> <volume>104</volume>, <fpage>307</fpage>–<lpage>313</lpage> (<year>2004</year>).</citation></ref><ref id="c28" hwp:id="ref-28"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Goemans BF"><given-names>BF</given-names> <surname>Goemans</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-29">Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia</article-title>. <source hwp:id="source-28">Br J Haematol</source> <volume>130</volume>, <fpage>801</fpage>–<lpage>803</lpage> (<year>2005</year>).</citation></ref><ref id="c29" hwp:id="ref-29"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Loh ML"><given-names>ML</given-names> <surname>Loh</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-30">Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia</article-title>. <source hwp:id="source-29">Leuk Res</source> <volume>29</volume>, <fpage>459</fpage>–<lpage>462</lpage> (<year>2005</year>).</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Pandey R"><given-names>R</given-names> <surname>Pandey</surname></string-name>, <string-name name-style="western" hwp:sortable="Saxena M"><given-names>M</given-names> <surname>Saxena</surname></string-name>, <string-name name-style="western" hwp:sortable="Kapur R"><given-names>R</given-names> <surname>Kapur</surname></string-name>, <article-title hwp:id="article-title-31">Role of SHP2 in hematopoiesis and leukemogenesis</article-title>. <source hwp:id="source-30">Curr Opin Hematol</source> <volume>24</volume>, <fpage>307</fpage>–<lpage>313</lpage> (<year>2017</year>).</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Neel BG"><given-names>BG</given-names> <surname>Neel</surname></string-name>, <string-name name-style="western" hwp:sortable="Gu H"><given-names>H</given-names> <surname>Gu</surname></string-name>, <string-name name-style="western" hwp:sortable="Pao L"><given-names>L</given-names> <surname>Pao</surname></string-name>, <article-title hwp:id="article-title-32">The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</article-title>. <source hwp:id="source-31">Trends Biochem. Sci</source> <volume>28</volume>, <fpage>284</fpage>–<lpage>293</lpage> (<year>2003</year>).</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Liu BA"><given-names>BA</given-names> <surname>Liu</surname></string-name>, <string-name name-style="western" hwp:sortable="Machida K"><given-names>K</given-names> <surname>Machida</surname></string-name>, <article-title hwp:id="article-title-33">Introduction: History of SH2 Domains and Their Applications</article-title>. <source hwp:id="source-32">Methods Mol Biol</source> <volume>1555</volume>, <fpage>3</fpage>–<lpage>35</lpage> (<year>2017</year>).</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Kaneko T"><given-names>T</given-names> <surname>Kaneko</surname></string-name>, <string-name name-style="western" hwp:sortable="Joshi R"><given-names>R</given-names> <surname>Joshi</surname></string-name>, <string-name name-style="western" hwp:sortable="Feller SM"><given-names>SM</given-names> <surname>Feller</surname></string-name>, <string-name name-style="western" hwp:sortable="Li SS"><given-names>SS</given-names> <surname>Li</surname></string-name>, <article-title hwp:id="article-title-34">Phosphotyrosine recognition domains: the typical, the atypical and the versatile</article-title>. <source hwp:id="source-33">Cell Commun Signal</source> <volume>10</volume>, <fpage>32</fpage> (<year>2012</year>).</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1 xref-ref-34-2 xref-ref-34-3 xref-ref-34-4 xref-ref-34-5 xref-ref-34-6 xref-ref-34-7 xref-ref-34-8"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Lee CH"><given-names>CH</given-names> <surname>Lee</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-35">Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase</article-title>. <source hwp:id="source-34">Structure</source> <volume>2</volume>, <fpage>423</fpage>–<lpage>438</lpage> (<year>1994</year>).</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Piccione E"><given-names>E</given-names> <surname>Piccione</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-36">Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding</article-title>. <source hwp:id="source-35">Biochemistry</source> <volume>32</volume>, <fpage>3197</fpage>–<lpage>3202</lpage> (<year>1993</year>).</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1 xref-ref-36-2 xref-ref-36-3"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Marasco M"><given-names>M</given-names> <surname>Marasco</surname></string-name>, <string-name name-style="western" hwp:sortable="Carlomagno T"><given-names>T</given-names> <surname>Carlomagno</surname></string-name>, <article-title hwp:id="article-title-37">Specificity and regulation of phosphotyrosine signaling through SH2 domains</article-title>. <source hwp:id="source-36">J Struct Biol X</source> <volume>4</volume>, <fpage>100026</fpage> (<year>2020</year>).</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1 xref-ref-37-2 xref-ref-37-3 xref-ref-37-4 xref-ref-37-5 xref-ref-37-6 xref-ref-37-7 xref-ref-37-8 xref-ref-37-9 xref-ref-37-10 xref-ref-37-11 xref-ref-37-12 xref-ref-37-13 xref-ref-37-14 xref-ref-37-15 xref-ref-37-16 xref-ref-37-17 xref-ref-37-18 xref-ref-37-19 xref-ref-37-20 xref-ref-37-21 xref-ref-37-22 xref-ref-37-23 xref-ref-37-24 xref-ref-37-25 xref-ref-37-26 xref-ref-37-27"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Hof P"><given-names>P</given-names> <surname>Hof</surname></string-name>, <string-name name-style="western" hwp:sortable="Pluskey S"><given-names>S</given-names> <surname>Pluskey</surname></string-name>, <string-name name-style="western" hwp:sortable="Dhe-Paganon S"><given-names>S</given-names> <surname>Dhe-Paganon</surname></string-name>, <string-name name-style="western" hwp:sortable="Eck MJ"><given-names>MJ</given-names> <surname>Eck</surname></string-name>, <string-name name-style="western" hwp:sortable="Shoelson SE"><given-names>SE</given-names> <surname>Shoelson</surname></string-name>, <article-title hwp:id="article-title-38">Crystal structure of the tyrosine phosphatase SHP-2</article-title>. <source hwp:id="source-37">Cell</source> <volume>92</volume>, <fpage>441</fpage>–<lpage>450</lpage> (<year>1998</year>).</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1 xref-ref-38-2"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="LaRochelle JR"><given-names>JR</given-names> <surname>LaRochelle</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-39">Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition</article-title>. <source hwp:id="source-38">Nat Commun</source> <volume>9</volume>, <fpage>4508</fpage> (<year>2018</year>).</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1 xref-ref-39-2 xref-ref-39-3 xref-ref-39-4 xref-ref-39-5 xref-ref-39-6 xref-ref-39-7 xref-ref-39-8 xref-ref-39-9 xref-ref-39-10 xref-ref-39-11 xref-ref-39-12 xref-ref-39-13 xref-ref-39-14"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Barford D"><given-names>D</given-names> <surname>Barford</surname></string-name>, <string-name name-style="western" hwp:sortable="Neel BG"><given-names>BG</given-names> <surname>Neel</surname></string-name>, <article-title hwp:id="article-title-40">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</article-title>. <source hwp:id="source-39">Structure</source> <volume>6</volume>, <fpage>249</fpage>–<lpage>254</lpage> (<year>1998</year>).</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1 xref-ref-40-2 xref-ref-40-3"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Bocchinfuso G"><given-names>G</given-names> <surname>Bocchinfuso</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-41">Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2</article-title>. <source hwp:id="source-40">Proteins</source> <volume>66</volume>, <fpage>963</fpage>–<lpage>974</lpage> (<year>2007</year>).</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1 xref-ref-41-2 xref-ref-41-3 xref-ref-41-4 xref-ref-41-5"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Darian E"><given-names>E</given-names> <surname>Darian</surname></string-name>, <string-name name-style="western" hwp:sortable="Guvench O"><given-names>O</given-names> <surname>Guvench</surname></string-name>, <string-name name-style="western" hwp:sortable="Yu B"><given-names>B</given-names> <surname>Yu</surname></string-name>, <string-name name-style="western" hwp:sortable="CK Qu J"><surname>CK Qu</surname> <given-names>J</given-names></string-name> <string-name name-style="western" hwp:sortable="MacKerell A.D."><surname>MacKerell</surname>, <given-names>A.D.</given-names></string-name>, <article-title hwp:id="article-title-42">Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase</article-title>. <source hwp:id="source-41">Proteins</source> <volume>79</volume>, <fpage>1573</fpage>–<lpage>1588</lpage> (<year>2011</year>).</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1 xref-ref-42-2 xref-ref-42-3"><label>42.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Lim WA"><given-names>WA</given-names> <surname>Lim</surname></string-name>, <article-title hwp:id="article-title-43">The modular logic of signaling proteins: building allosteric switches from simple binding domains</article-title>. <source hwp:id="source-42">Curr Opin Struct Biol</source> <volume>12</volume>, <fpage>61</fpage>–<lpage>68</lpage> (<year>2002</year>).</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1 xref-ref-43-2 xref-ref-43-3 xref-ref-43-4 xref-ref-43-5 xref-ref-43-6 xref-ref-43-7"><label>43.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Anselmi M"><given-names>M</given-names> <surname>Anselmi</surname></string-name>, <string-name name-style="western" hwp:sortable="Hub JS"><given-names>JS</given-names> <surname>Hub</surname></string-name>, <article-title hwp:id="article-title-44">An allosteric interaction controls the activation mechanism of shp2 tyrosine phosphatase</article-title>. <source hwp:id="source-43">Sci. Reports</source> <volume>10</volume>, <fpage>18530</fpage> (<year>2020</year>).</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1 xref-ref-44-2"><label>44.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Williams CJ"><given-names>CJ</given-names> <surname>Williams</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-45">MolProbity: More and better reference data for improved all-atom structure validation</article-title>. <source hwp:id="source-44">Protein Sci</source> <volume>27</volume>, <fpage>293</fpage>–<lpage>315</lpage> (<year>2018</year>).</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>45.</label><citation publication-type="other" citation-type="journal" ref:id="388447v3.45" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Laskowski RA"><given-names>RA</given-names> <surname>Laskowski</surname></string-name>, <article-title hwp:id="article-title-46">Structural quality assurance</article-title>. <source hwp:id="source-45">Struct. Bioinforma</source>., <fpage>273</fpage>–<lpage>303</lpage> (<year>2003</year>).</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1 xref-ref-46-2 xref-ref-46-3"><label>46.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Pražnikar J"><given-names>J</given-names> <surname>Pražnikar</surname></string-name>, <string-name name-style="western" hwp:sortable="Tomić M"><given-names>M</given-names> <surname>Tomić</surname></string-name>, <string-name name-style="western" hwp:sortable="Turk D"><given-names>D</given-names> <surname>Turk</surname></string-name>, <article-title hwp:id="article-title-47">Validation and quality assessment of macromolecular structures using complex network analysis</article-title>. <source hwp:id="source-46">Sci. reports</source> <volume>9</volume>, <fpage>1678</fpage>–<lpage>1678</lpage> (<year>2019</year>).</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><label>47.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Tickle IJ"><given-names>IJ</given-names> <surname>Tickle</surname></string-name>, <article-title hwp:id="article-title-48">Statistical quality indicators for electron-density maps</article-title>. <source hwp:id="source-47">Acta crystallographica. Sect. D, Biol. crystallography</source> <volume>68</volume>, <fpage>454</fpage>–<lpage>467</lpage> (<year>2012</year>).</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1 xref-ref-48-2 xref-ref-48-3 xref-ref-48-4 xref-ref-48-5"><label>48.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Kleywegt GJ"><given-names>GJ</given-names> <surname>Kleywegt</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-49">The Uppsala Electron-Density Server</article-title>. <source hwp:id="source-48">Acta Crystallogr. Sect. D</source> <volume>60</volume>, <fpage>2240</fpage>–<lpage>2249</lpage> (<year>2004</year>).</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1 xref-ref-49-2 xref-ref-49-3 xref-ref-49-4 xref-ref-49-5 xref-ref-49-6 xref-ref-49-7"><label>49.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="LaRochelle JR"><given-names>JR</given-names> <surname>LaRochelle</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-50">Structural and functional consequences of three cancer-associated mutations of the oncogenic phosphatase SHP2</article-title>. <source hwp:id="source-49">Biochemistry</source> <volume>55</volume>, <fpage>2269</fpage>–<lpage>2277</lpage> (<year>2016</year>).</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1 xref-ref-50-2 xref-ref-50-3 xref-ref-50-4 xref-ref-50-5 xref-ref-50-6 xref-ref-50-7 xref-ref-50-8 xref-ref-50-9"><label>50.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Yu ZH"><given-names>ZH</given-names> <surname>Yu</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-51">Molecular basis of gain-of-function LEOPARD syndrome-associated SHP2 mutations</article-title>. <source hwp:id="source-50">Biochemistry</source> <volume>53</volume>, <fpage>4136</fpage>–<lpage>4151</lpage> (<year>2014</year>).</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><label>51.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Anselmi M"><given-names>M</given-names> <surname>Anselmi</surname></string-name>, <string-name name-style="western" hwp:sortable="Brunori M"><given-names>M</given-names> <surname>Brunori</surname></string-name>, <string-name name-style="western" hwp:sortable="Vallone B"><given-names>B</given-names> <surname>Vallone</surname></string-name>, <string-name name-style="western" hwp:sortable="Nola A Di"><given-names>A Di</given-names> <surname>Nola</surname></string-name>, <article-title hwp:id="article-title-52">Molecular dynamics simulation of the neuroglobin crystal: comparison with the simulation in solution</article-title>. <source hwp:id="source-51">Biophys J</source> <volume>95</volume>, <fpage>4157</fpage>–<lpage>4162</lpage> (<year>2008</year>).</citation></ref><ref id="c52" hwp:id="ref-52"><label>52.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Cerutti DS"><given-names>DS</given-names> <surname>Cerutti</surname></string-name>, <string-name name-style="western" hwp:sortable="Trong I Le"><given-names>I Le</given-names> <surname>Trong</surname></string-name>, <string-name name-style="western" hwp:sortable="Stenkamp RE"><given-names>RE</given-names> <surname>Stenkamp</surname></string-name>, <string-name name-style="western" hwp:sortable="Lybrand TP"><given-names>TP</given-names> <surname>Lybrand</surname></string-name>, <article-title hwp:id="article-title-53">Dynamics of the streptavidin-biotin complex in solution and in its crystal lattice: distinct behavior revealed by molecular simulations</article-title>. <source hwp:id="source-52">J Phys Chem B</source> <volume>113</volume>, <fpage>6971</fpage>–<lpage>6985</lpage> (<year>2009</year>).</citation></ref><ref id="c53" hwp:id="ref-53"><label>53.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Vorontsov I"><given-names>I</given-names> <surname>Vorontsov</surname></string-name>, <string-name name-style="western" hwp:sortable="Miyashita O"><given-names>O</given-names> <surname>Miyashita</surname></string-name>, <article-title hwp:id="article-title-54">Solution and crystal molecular dynamics simulation study of m4cyanovirin-N mutants complexed with di-mannose</article-title>. <source hwp:id="source-53">Biophys J</source> <volume>97</volume>, <fpage>2532</fpage>–<lpage>2540</lpage> (<year>2009</year>).</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><label>54.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Zhang Z"><given-names>Z</given-names> <surname>Zhang</surname></string-name>, <string-name name-style="western" hwp:sortable="Wriggers W"><given-names>W</given-names> <surname>Wriggers</surname></string-name>, <article-title hwp:id="article-title-55">Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization</article-title>. <source hwp:id="source-54">Biochemistry</source> <volume>50</volume>, <fpage>2144</fpage>–<lpage>2156</lpage> (<year>2011</year>).</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1"><label>55.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Eck MJ"><given-names>MJ</given-names> <surname>Eck</surname></string-name>, <string-name name-style="western" hwp:sortable="Pluskey S"><given-names>S</given-names> <surname>Pluskey</surname></string-name>, <string-name name-style="western" hwp:sortable="Trüb T"><given-names>T</given-names> <surname>Trüb</surname></string-name>, <string-name name-style="western" hwp:sortable="Harrison SC"><given-names>SC</given-names> <surname>Harrison</surname></string-name>, <string-name name-style="western" hwp:sortable="Shoelson SE"><given-names>SE</given-names> <surname>Shoelson</surname></string-name>, <article-title hwp:id="article-title-56">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</article-title>. <source hwp:id="source-55">Nature</source> <volume>379</volume>, <fpage>277</fpage>–<lpage>280</lpage> (<year>1996</year>).</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><label>56.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.56" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Laskowski RA"><given-names>RA</given-names> <surname>Laskowski</surname></string-name>, <string-name name-style="western" hwp:sortable="Gerick F"><given-names>F</given-names> <surname>Gerick</surname></string-name>, <string-name name-style="western" hwp:sortable="Thornton JM"><given-names>JM</given-names> <surname>Thornton</surname></string-name>, <article-title hwp:id="article-title-57">The structural basis of allosteric regulation in proteins</article-title>. <source hwp:id="source-56">FEBS Lett</source> <volume>583</volume>, <fpage>1692</fpage>–<lpage>1698</lpage> (<year>2009</year>).</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1"><label>57.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Tsai CJ"><given-names>CJ</given-names> <surname>Tsai</surname></string-name>, <string-name name-style="western" hwp:sortable="Sol A Del"><given-names>A Del</given-names> <surname>Sol</surname></string-name>,<string-name name-style="western" hwp:sortable="Nussinov R"><given-names>R</given-names> <surname>Nussinov</surname></string-name>, <article-title hwp:id="article-title-58">Protein allostery, signal transmission and dynamics: a classification scheme of allosteric mechanisms</article-title>. <source hwp:id="source-57">Mol Biosyst</source> <volume>5</volume>, <fpage>207</fpage>–<lpage>216</lpage> (<year>2009</year>).</citation></ref><ref id="c58" hwp:id="ref-58" hwp:rev-id="xref-ref-58-1"><label>58.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.58" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-58"><string-name name-style="western" hwp:sortable="Minor DL"><given-names>DL</given-names> <surname>Minor</surname></string-name>, <string-name name-style="western" hwp:sortable="Kim PS"><given-names>PS</given-names> <surname>Kim</surname></string-name>, <article-title hwp:id="article-title-59">Measurement of the β-sheet-forming propensities of amino acids</article-title>. <source hwp:id="source-58">Nature</source> <volume>367</volume>, <fpage>660</fpage>–<lpage>663</lpage> (<year>1994</year>).</citation></ref><ref id="c59" hwp:id="ref-59" hwp:rev-id="xref-ref-59-1"><label>59.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.59" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-59"><string-name name-style="western" hwp:sortable="Emsley P"><given-names>P</given-names> <surname>Emsley</surname></string-name>, <string-name name-style="western" hwp:sortable="Lohkamp B"><given-names>B</given-names> <surname>Lohkamp</surname></string-name>, <string-name name-style="western" hwp:sortable="Scott WG"><given-names>WG</given-names> <surname>Scott</surname></string-name>, <string-name name-style="western" hwp:sortable="Cowtan K"><given-names>K</given-names> <surname>Cowtan</surname></string-name>, <article-title hwp:id="article-title-60">Features and development of Coot</article-title>. <source hwp:id="source-59">Acta Crystallogr D Biol Crystallogr</source> <volume>66</volume>, <fpage>486</fpage>–<lpage>501</lpage> (<year>2010</year>).</citation></ref><ref id="c60" hwp:id="ref-60" hwp:rev-id="xref-ref-60-1 xref-ref-60-2 xref-ref-60-3 xref-ref-60-4"><label>60.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.60" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-60"><string-name name-style="western" hwp:sortable="Jorgensen WL"><given-names>WL</given-names> <surname>Jorgensen</surname></string-name>, <string-name name-style="western" hwp:sortable="Chandrasekhar J"><given-names>J</given-names> <surname>Chandrasekhar</surname></string-name>, <string-name name-style="western" hwp:sortable="Madura JD"><given-names>JD</given-names> <surname>Madura</surname></string-name>, <string-name name-style="western" hwp:sortable="Impey RW"><given-names>RW</given-names> <surname>Impey</surname></string-name>, <string-name name-style="western" hwp:sortable="Klein ML"><given-names>ML</given-names> <surname>Klein</surname></string-name>, <article-title hwp:id="article-title-61">Comparison of simple potential functions for simulating liquid water</article-title>. <source hwp:id="source-60">J. Chem. Phys</source>. <volume>79</volume>, <fpage>926</fpage>–<lpage>935</lpage> (<year>1983</year>).</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1"><label>61.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.61" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="Van Der Spoel D"><given-names>D</given-names> <surname>Van Der Spoel</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-62">GROMACS: fast, flexible, and free</article-title>. <source hwp:id="source-61">J Comput. Chem</source> <volume>26</volume>, <fpage>1701</fpage>–<lpage>1718</lpage> (<year>2005</year>).</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1 xref-ref-62-2"><label>62.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><string-name name-style="western" hwp:sortable="Aliev AE"><given-names>AE</given-names> <surname>Aliev</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-63">Motional timescale predictions by molecular dynamics simulations: case study using proline and hydroxyproline sidechain dynamics</article-title>. <source hwp:id="source-62">Proteins</source> <volume>82</volume>, <fpage>195</fpage>–<lpage>215</lpage> (<year>2014</year>).</citation></ref><ref id="c63" hwp:id="ref-63" hwp:rev-id="xref-ref-63-1 xref-ref-63-2"><label>63.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="Best RB"><given-names>RB</given-names> <surname>Best</surname></string-name>, <string-name name-style="western" hwp:sortable="Hummer G"><given-names>G</given-names> <surname>Hummer</surname></string-name>, <article-title hwp:id="article-title-64">Optimized molecular dynamics force fields applied to the helix-coil transition of polypeptides</article-title>. <source hwp:id="source-63">J Phys Chem B</source> <volume>113</volume>, <fpage>9004</fpage>–<lpage>9015</lpage> (<year>2009</year>).</citation></ref><ref id="c64" hwp:id="ref-64" hwp:rev-id="xref-ref-64-1"><label>64.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="Darden T"><given-names>T</given-names> <surname>Darden</surname></string-name>, <string-name name-style="western" hwp:sortable="York D"><given-names>D</given-names> <surname>York</surname></string-name>, <string-name name-style="western" hwp:sortable="Pedersen L"><given-names>L</given-names> <surname>Pedersen</surname></string-name>, <article-title hwp:id="article-title-65">Particle Mesh Ewald: an Nlog(N) method for Ewald sum in large systems</article-title>. <source hwp:id="source-64">J. Chem. Phys</source>. <volume>98</volume>, <fpage>10089</fpage>–<lpage>10092</lpage> (<year>1993</year>).</citation></ref><ref id="c65" hwp:id="ref-65" hwp:rev-id="xref-ref-65-1"><label>65.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.65" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Miyamoto S"><given-names>S</given-names> <surname>Miyamoto</surname></string-name>, <string-name name-style="western" hwp:sortable="Kollman PA"><given-names>PA</given-names> <surname>Kollman</surname></string-name>, <article-title hwp:id="article-title-66">SETTLE: An analytical version of the SHAKE and RATTLE algorithms for rigid water models</article-title>.. <source hwp:id="source-65">J. Comp. Chem</source>. <volume>13</volume>, <fpage>952</fpage>–<lpage>962</lpage> (<year>1992</year>).</citation></ref><ref id="c66" hwp:id="ref-66" hwp:rev-id="xref-ref-66-1"><label>66.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Hess B"><given-names>B</given-names> <surname>Hess</surname></string-name>, <string-name name-style="western" hwp:sortable="Bekker H"><given-names>H</given-names> <surname>Bekker</surname></string-name>, <string-name name-style="western" hwp:sortable="Berendsen HJC"><given-names>HJC</given-names> <surname>Berendsen</surname></string-name>, <article-title hwp:id="article-title-67">JGEM Fraaije, LINCS: a linear constraint solver for molecular simulations</article-title>. <source hwp:id="source-66">J. Comput. Chem</source>. <volume>18</volume>, <fpage>1463</fpage>–<lpage>1472</lpage> (<year>1997</year>).</citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><label>67.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Parrinello M"><given-names>M</given-names> <surname>Parrinello</surname></string-name>, <string-name name-style="western" hwp:sortable="Rahman A"><given-names>A</given-names> <surname>Rahman</surname></string-name>, <article-title hwp:id="article-title-68">Polymorphic transitions in single crystals: A new molecular dynamics method</article-title>. <source hwp:id="source-67">J. Appl. Phys</source>. <volume>52</volume>, <fpage>7182</fpage>–<lpage>7190</lpage> (<year>1981</year>).</citation></ref><ref id="c68" hwp:id="ref-68" hwp:rev-id="xref-ref-68-1"><label>68.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.68" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-68"><string-name name-style="western" hwp:sortable="Bussi G"><given-names>G</given-names> <surname>Bussi</surname></string-name>, <string-name name-style="western" hwp:sortable="Donadio D"><given-names>D</given-names> <surname>Donadio</surname></string-name>, <string-name name-style="western" hwp:sortable="Parrinello M"><given-names>M</given-names> <surname>Parrinello</surname></string-name>, <article-title hwp:id="article-title-69">Canonical sampling through velocity rescaling</article-title>. <source hwp:id="source-68">J. Chem. Phys</source>. <volume>126</volume>, <fpage>14101</fpage> (<year>2007</year>).</citation></ref><ref id="c69" hwp:id="ref-69" hwp:rev-id="xref-ref-69-1 xref-ref-69-2"><label>69.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.69" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-69"><string-name name-style="western" hwp:sortable="Grubmuller H"><given-names>H</given-names> <surname>Grubmuller</surname></string-name>, <string-name name-style="western" hwp:sortable="Heymann B"><given-names>B</given-names> <surname>Heymann</surname></string-name>, <string-name name-style="western" hwp:sortable="Tavan P"><given-names>P</given-names> <surname>Tavan</surname></string-name>, <article-title hwp:id="article-title-70">Ligand binding: molecular mechanics calculation of the streptavidin-biotin rupture force</article-title>. <source hwp:id="source-69">Science</source> <volume>271</volume>, <fpage>997</fpage>–<lpage>999</lpage> (<year>1996</year>).</citation></ref><ref id="c70" hwp:id="ref-70" hwp:rev-id="xref-ref-70-1"><label>70.</label><citation publication-type="book" citation-type="book" ref:id="388447v3.70" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-70"><string-name name-style="western" hwp:sortable="Izrailev S"><given-names>S</given-names> <surname>Izrailev</surname></string-name>, <etal>et al.</etal>, <source hwp:id="source-70">Steered molecular dynamics</source>. (<publisher-name>Springer-Verlag</publisher-name>), pp. <fpage>39</fpage>–<lpage>65</lpage> (<year>1998</year>).</citation></ref><ref id="c71" hwp:id="ref-71" hwp:rev-id="xref-ref-71-1 xref-ref-71-2 xref-ref-71-3 xref-ref-71-4 xref-ref-71-5 xref-ref-71-6"><label>71.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.71" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-71"><string-name name-style="western" hwp:sortable="Marinari E"><given-names>E</given-names> <surname>Marinari</surname></string-name>, <string-name name-style="western" hwp:sortable="Parisi G"><given-names>G</given-names> <surname>Parisi</surname></string-name>, <article-title hwp:id="article-title-71">Simulated tempering: a new Monte Carlo scheme</article-title>. <source hwp:id="source-71">Eur. Lett</source>. <volume>19</volume>, <fpage>451</fpage>– <lpage>458</lpage> (<year>1992</year>).</citation></ref><ref id="c72" hwp:id="ref-72" hwp:rev-id="xref-ref-72-1 xref-ref-72-2"><label>72.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.72" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-72"><string-name name-style="western" hwp:sortable="Park S"><given-names>S</given-names> <surname>Park</surname></string-name>, <string-name name-style="western" hwp:sortable="Pande VS"><given-names>VS</given-names> <surname>Pande</surname></string-name>, <article-title hwp:id="article-title-72">Choosing weights for simulated tempering</article-title>. <source hwp:id="source-72">Phys Rev E Stat Nonlin Soft Matter Phys</source> <volume>76</volume>, <fpage>016703</fpage> (<year>2007</year>).</citation></ref><ref id="c73" hwp:id="ref-73" hwp:rev-id="xref-ref-73-1"><label>73.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.73" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-73"><string-name name-style="western" hwp:sortable="Wang F"><given-names>F</given-names> <surname>Wang</surname></string-name>, <string-name name-style="western" hwp:sortable="Landhow DP"><given-names>DP</given-names> <surname>Landhow</surname></string-name> <article-title hwp:id="article-title-73">to insertau, Efficient, multiple-range random walk algorithm to calculate the density of states</article-title>. <source hwp:id="source-73">Phys Rev Lett</source> <volume>86</volume>, <fpage>2050</fpage>–<lpage>2053</lpage> (<year>2001</year>).</citation></ref><ref id="c74" hwp:id="ref-74" hwp:rev-id="xref-ref-74-1 xref-ref-74-2 xref-ref-74-3 xref-ref-74-4"><label>74.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.74" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-74"><string-name name-style="western" hwp:sortable="Hub JS"><given-names>JS</given-names> <surname>Hub</surname></string-name>, <string-name name-style="western" hwp:sortable="de Groot BL"><given-names>BL</given-names> <surname>de Groot</surname></string-name>, <string-name name-style="western" hwp:sortable="van der Spoel D"><given-names>D</given-names> <surname>van der Spoel</surname></string-name>, <article-title hwp:id="article-title-74">g_wham—A Free Weighted Histogram Analysis Implementation Including Robust Error and Autocorrelation Estimates</article-title>. <source hwp:id="source-74">J. Chem. Theory Comput</source>. <volume>6</volume>, <fpage>3713</fpage>–<lpage>3720</lpage> (<year>2010</year>).</citation></ref><ref id="c75" hwp:id="ref-75" hwp:rev-id="xref-ref-75-1 xref-ref-75-2"><label>75.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.75" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-75"><string-name name-style="western" hwp:sortable="Kumar S"><given-names>S</given-names> <surname>Kumar</surname></string-name>, <string-name name-style="western" hwp:sortable="Bouzida D"><given-names>D</given-names> <surname>Bouzida</surname></string-name>, <string-name name-style="western" hwp:sortable="Swendsen SH"><given-names>SH</given-names> <surname>Swendsen</surname></string-name>, <string-name name-style="western" hwp:sortable="Kollman PA"><given-names>PA</given-names> <surname>Kollman</surname></string-name>, <string-name name-style="western" hwp:sortable="Rosenberg JM"><given-names>JM</given-names> <surname>Rosenberg</surname></string-name>, <article-title hwp:id="article-title-75">The Weighted Histogram Analysis Method for free-energy calculations on biomolecules. I. the method</article-title>. <source hwp:id="source-75">J. Comput. Chem</source>. <volume>13</volume>, <fpage>1011</fpage>–<lpage>1021</lpage> (<year>1992</year>).</citation></ref><ref id="c76" hwp:id="ref-76" hwp:rev-id="xref-ref-76-1 xref-ref-76-2"><label>76.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.76" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-76"><string-name name-style="western" hwp:sortable="Daura X"><given-names>X</given-names> <surname>Daura</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-76">Peptide Folding: When Simulation Meets Experiment</article-title>. <source hwp:id="source-76">Angewandte Chemie Int</source>. Ed. <volume>38</volume>, <fpage>236</fpage>–<lpage>240</lpage> (<year>1999</year>).</citation></ref><ref id="c77" hwp:id="ref-77" hwp:rev-id="xref-ref-77-1"><label>77.</label><citation publication-type="other" citation-type="journal" ref:id="388447v3.77" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-77"><collab hwp:id="collab-1">Chemical Computing Group Inc</collab>., <source hwp:id="source-77">Molecular Operating Environment (MOE) software</source> (<year>2014</year>).</citation></ref><ref id="c78" hwp:id="ref-78" hwp:rev-id="xref-ref-78-1"><label>78.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.78" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-78"><string-name name-style="western" hwp:sortable="Best RB"><given-names>RB</given-names> <surname>Best</surname></string-name>, <string-name name-style="western" hwp:sortable="Zheng W"><given-names>W</given-names> <surname>Zheng</surname></string-name>, <string-name name-style="western" hwp:sortable="Mittal J"><given-names>J</given-names> <surname>Mittal</surname></string-name>, <article-title hwp:id="article-title-77">Balanced protein–water interactions improve properties of disordered proteins and non-specific protein association</article-title>. <source hwp:id="source-78">J. Chem. Theory Comput</source>. <volume>10</volume>, <fpage>5113</fpage>– <lpage>5124</lpage> (<year>2014</year>).</citation></ref><ref id="c79" hwp:id="ref-79" hwp:rev-id="xref-ref-79-1"><label>79.</label><citation publication-type="journal" citation-type="journal" ref:id="388447v3.79" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-79"><string-name name-style="western" hwp:sortable="Huang J"><given-names>J</given-names> <surname>Huang</surname></string-name>, <etal>et al.</etal>, <article-title hwp:id="article-title-78">CHARMM36m: an improved force field for folded and intrinsically disordered proteins</article-title>. <source hwp:id="source-79">Nat Methods</source> <volume>14</volume>, <fpage>71</fpage>–<lpage>73</lpage> (<year>2017</year>).</citation></ref></ref-list></back></article>
